Fabric ventilation assembly
The patient interface and CPAP system with innovative ventilation design address discomfort and complexity issues, enhancing compliance and efficacy in treating breathing disorders by maintaining therapeutic pressure and reducing noise.
Patent Information
- Application Number
- CN202411175620.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2019-07-30
- Filing Date
- 2020-02-21
- Publication Date
- 2024-12-06
AI Technical Summary
Existing respiratory therapies for breathing disorders, such as CPAP and NIV, face challenges with patient compliance due to discomfort, complexity, and inefficiency, particularly in treating conditions like obstructive sleep apnea and respiratory failure, as current masks and devices are often unsightly, difficult to use, and uncomfortable, leading to reduced adherence.
A patient interface with an inflatable chamber, seal-forming structure, positioning and stabilizing structure, and vent structure that maintains therapeutic pressure while allowing unpressurized mouth breathing and continuous exhalation, along with a CPAP system incorporating a ventilation assembly with diffuser members and orifices to minimize noise and discomfort.
Enhances patient compliance and comfort by reducing mask-related issues, minimizing noise, and improving ease of use, making therapy more effective and user-friendly for long-term adherence.
Smart Images

Figure CN119075104A_ABST
Abstract
Description
[0001] A portion of the disclosure of this patent document contains material which is subject to copyright protection. The copyright owner has no objection to the facsimile reproduction by anyone of the patent document or the patent disclosure, as it appears in the Patent Office patent file or records, but otherwise reserves all copyright rights whatsoever.
[0002] 1 Cross-reference to related applications
[0003] This application is a divisional application of a patent application with application number 202080027313.X, application date February 21, 2020, and invention name “Fabric Ventilation Component”, and the patent application with application number 202080027313.X is the Chinese national phase application of international application PCT / IB2020 / 051474 filed on February 21, 2020, which claims the benefits of U.S. Provisional Application No. 62 / 808,901 filed on February 22, 2019 and U.S. Provisional Application No. 62 / 880,338 filed on July 30, 2019, each of which is incorporated herein by reference in its entirety. Technical Background 2.1 Technical Field
[0004] The present technology relates to one or more of the screening, diagnosis, monitoring, treatment, prevention and improvement of breathing-related disorders. The present technology also relates to medical devices or equipment and their uses.
[0005] 2.2 Description of related technologies
[0006] 2.2.1 Human respiratory system and its disorders
[0007] The human respiratory system facilitates gas exchange. The nose and mouth form the entrance to the patient's airway.
[0008] The airway includes a series of branching tracheae, which become narrower, shorter and more numerous as they penetrate deeper into the lungs. The main function of the lungs is gas exchange, allowing oxygen to enter the venous blood from the inhaled air and expel carbon dioxide from the opposite direction. The trachea is divided into the left main bronchi and the right main bronchi, which are eventually divided into terminal bronchioles. The bronchi constitute the conducting airways, but do not participate in gas exchange. Further branches of the airway lead to the respiratory bronchioles and eventually to the alveoli. The alveolar region of the lungs is the area where gas exchange occurs and is called the respiratory zone. See "Respiratory Physiology", 9th edition, published by John B.West, Lippincott Williams & Wilkins in 2012.
[0009] There is a range of breathing disorders. Some disorders can be characterised by specific events such as apnea, hypopnea and hyperpnea.
[0010] Examples of breathing disorders include obstructive sleep apnea (OSA), Cheyne-Stokes Respiration (CSR), respiratory insufficiency, obesity hyperventilation syndrome (OHS), chronic obstructive pulmonary disease (COPD), neuromuscular disease (NMD), and chest wall disease.
[0011] Obstructive Sleep Apnea (OSA) is a form of sleep disordered breathing (SDB) characterized by events including occlusion or obstruction of the upper airway during sleep. It results from a combination of an abnormally small upper airway and normal loss of muscle tone in the area of the tongue, soft palate, and posterior oropharyngeal wall during sleep. The condition causes affected patients to stop breathing, typically for periods of 30 to 120 seconds, sometimes 200 to 300 times per night. This often leads to excessive daytime sleepiness and can lead to cardiovascular disease and brain damage. Complications are common disorders, especially in middle-aged overweight men, but those affected may not be aware of the problem. See U.S. Patent No. 4,944,310 (Sullivan).
[0012] Cheyne-Stokes respiration (CSR) is another form of sleep-disordered breathing. CSR is a disorder of the patient's respiratory controller in which there are rhythmic alternating cycles of boom-and-bust ventilation called CSR cycles. CSR is characterized by repeated hypoxia and reoxygenation of arterial blood. CSR can be harmful because of the repeated lack of oxygen. In some patients, CSR is associated with repeated arousals from sleep, which leads to severe sleep disruption, increased sympathetic activity, and increased afterload. See U.S. Patent No. 6,532,959 (Berthon-Jones).
[0013] Respiratory failure is an umbrella term for breathing disorders in which the lungs cannot take in enough oxygen or exhale enough CO2 to meet the patient's needs. Respiratory failure may include some or all of the following disorders.
[0014] Patients with respiratory insufficiency, a form of respiratory failure, may experience abnormal shortness of breath during exercise.
[0015] Obesity Hyperventilation Syndrome (OHS) is defined as the combination of severe obesity and chronic hypercapnia during wakefulness in the absence of other known causes of hypoventilation. Symptoms include dyspnea, morning headache, and excessive daytime sleepiness.
[0016] Chronic obstructive pulmonary disease (COPD) includes any of a group of lower airway diseases that have certain common features. These diseases include increased resistance to air flow, prolonged expiratory phase of breathing, and loss of normal elasticity of the lungs. Examples of COPD are emphysema and chronic bronchitis. COPD is caused by chronic smoking (a major risk factor), occupational exposure, air pollution, and genetic factors. Symptoms include: dyspnea on exertion, chronic cough, and sputum production.
[0017] Neuromuscular disease (NMD) is a broad term that covers many diseases and disorders that impair muscle function directly through intrinsic muscle pathology or indirectly through neuropathology. Some NMD patients are characterized by progressive muscle damage, which leads to loss of walking ability, wheelchair use, dysphagia, respiratory muscle weakness, and ultimately death from respiratory failure. Neuromuscular disorders can be divided into rapidly progressive and slowly progressive: (i) rapidly progressive disorders: characterized by muscle damage over several months and leading to death within a few years (e.g., juvenile amyotrophic lateral sclerosis (ALS) and Duchenne muscular dystrophy (DMD)); (ii) variable or slowly progressive diseases: characterized by worsening muscle damage over several years and only slightly shortening life expectancy (e.g., limb-girdle muscular dystrophy, facioscapulohumeral muscular dystrophy and myotonic dystrophy). Symptoms of respiratory failure in NMD include increasing general weakness, difficulty swallowing, dyspnea during exertion and at rest, fatigue, lethargy, morning headaches, and difficulty concentrating and mood changes.
[0018] Chest wall disorders are a group of chest deformities that result in inefficient connections between the respiratory muscles and the thorax. These disorders are usually characterized by restrictive defects and have the potential for long-term hypercapnic respiratory failure. Scoliosis and / or kyphoscoliosis can cause severe respiratory failure. Symptoms of respiratory failure include: dyspnea during exertion, peripheral edema, orthopnea, recurrent chest infections, morning headaches, fatigue, poor sleep quality, and loss of appetite.
[0019] A range of treatments have been used to treat or improve such conditions. In addition, such treatments can be used to prevent breathing disorders in otherwise healthy individuals. However, these treatments have a number of disadvantages.
[0020] 2.2.2 Treatment
[0021] Various therapies, such as continuous positive airway pressure (CPAP) therapy, non-invasive ventilation (NIV), and invasive ventilation (IV) have been used to treat one or more of the above-mentioned respiratory diseases.
[0022] Continuous Positive Airway Pressure (CPAP) therapy has been used to treat obstructive sleep apnea (OSA). The mechanism of action is that the continuous positive airway pressure acts as a pneumatic splint and can prevent upper airway occlusion, such as by pushing the soft palate and tongue forward and away from the posterior oropharyngeal wall. Treatment of OSA treated by CPAP can be voluntary, so if the patient finds the device used to provide such treatment to be any one or more of: uncomfortable, difficult to use, expensive, and unsightly, the patient may choose not to comply with the treatment.
[0023] Non-invasive ventilation (NIV) provides ventilation support to patients through the upper airway to help them breathe and / or maintain appropriate oxygen levels in the body by completing some or all of the work of breathing. Ventilatory support is provided via a non-invasive patient interface. NIV has been used to treat CSR and respiratory failure in the form of OHS, COPD, NMD, and chest wall disease. In some forms, the comfort and effectiveness of these treatments can be improved.
[0024] Non-invasive ventilation (IV) provides ventilation support to patients who are unable to breathe effectively on their own and can be provided using a tracheostomy tube. In some forms, the comfort and effectiveness of these treatments can be improved.
[0025] 2.2.3 Treatment system
[0026] These treatments can be provided by a therapeutic system or device.Such systems and devices can also be used to screen, diagnose or monitor a condition without treating the condition.
[0027] The therapy system may include a respiratory pressure therapy device (RPT device), air circuit, humidifier, patient interface, and data management.
[0028] Another form of treatment system is a mandibular repositioning device.
[0029] 2.2.3.1 Patient interface
[0030] The patient interface can be used to engage the respiratory apparatus to its wearer, for example by providing an air flow to the entrance of the airway. The air flow can be provided to the patient's nose and / or mouth via a mask, to the mouth via a tube, or to the patient's trachea via a tracheostomy tube. Depending on the treatment to be applied, the patient interface can form a seal with an area such as the patient's face, thereby causing gas to be delivered at a pressure that is sufficiently different from the ambient pressure (e.g., a positive pressure of approximately 10 cmH2O relative to the ambient pressure) to achieve the treatment. For other forms of treatment, such as oxygen delivery, the patient interface may not include a seal sufficient to deliver gas at a positive pressure of approximately 10 cmH2O to the airway.
[0031] Certain other mask systems may not be functionally suitable for use in this field. For example, a purely decorative mask may not be able to maintain a suitable pressure. Masks used for underwater swimming or diving may be configured to prevent water from flowing in from an external high pressure, rather than maintaining air at a higher pressure than the environment inside.
[0032] Certain masks may be clinically disadvantageous to the present technology, for example where they block airflow through the nose and only allow it through the mouth.
[0033] Certain masks may be uncomfortable or impractical for the present technology if they require the patient to insert a portion of the mask structure into their mouth to form and maintain a seal with their lips.
[0034] Certain masks may not be feasible for use while sleeping, such as when sleeping on one's side in bed with the head on a pillow.
[0035] The design of a patient interface presents several challenges. The face has a complex three-dimensional shape. The size and shape of the nose and head vary significantly from person to person. Because the head is composed of bone, cartilage, and soft tissue, different areas of the face react differently to mechanical forces. The jaw or mandible can move relative to other bones of the skull. The entire head can move during a respiratory therapy session.
[0036] Due to these challenges, some masks face one or more of the following problems: obtrusive, unsightly, expensive, disproportionate, difficult to use, and uncomfortable, especially when worn for long periods of time or when the patient is not familiar with the system. A mask of the wrong size can cause reduced compliance, reduced comfort, and adverse patient outcomes. Masks designed only for pilots, masks designed to be part of personal protective equipment (e.g., filtering masks), SCUBA masks, or masks designed to apply anesthetics are acceptable for their original purposes, but are not as comfortable as ideal for long periods of time (e.g., several hours). This discomfort may lead to reduced patient compliance with therapy. This is even more true if the mask is worn during sleep.
[0037] CPAP therapy is very effective in treating certain breathing disorders, assuming the patient complies with the therapy. If the mask is uncomfortable or difficult to use, the patient may not comply with the therapy. Since patients are often advised to wash their masks regularly, if the mask is difficult to clean (e.g., difficult to assemble or disassemble), the patient may not wash their mask, which may affect patient compliance.
[0038] While masks used in other applications (eg, pilots) may not be suitable for treating sleep disordered breathing, masks designed for treating sleep disordered breathing may be suitable for other applications.
[0039] For these reasons, a diverse field of patient interfaces for delivering CPAP during sleep has emerged.
[0040] 2.2.3.1.1 Sealing structure
[0041] The patient interface may include a seal-forming structure. Since it is in direct contact with the patient's face, the shape and configuration of the seal-forming structure may directly affect the effectiveness and comfort of the patient interface.
[0042] The patient interface is characterized in part according to the design intent of the seal-forming structure to engage with the face when in use. In one form of the patient interface, the seal-forming structure may include a first sub-portion and a second sub-portion, the first sub-portion forming a seal around the left nostril and the second sub-portion forming a seal around the right nostril. In one form of the patient interface, the seal-forming structure may include a single element that surrounds both nostrils when in use. Such a single element may be designed to, for example, cover the upper lip area and the bridge of the nose area of the face. In one form of the patient interface, the seal-forming structure may include an element that surrounds the mouth area when in use, for example, by forming a seal on the lower lip area of the face. In one form of the patient interface, the seal-forming structure may include a single element that surrounds both nostrils and the mouth area when in use. These different types of patient interfaces may be given various names by their manufacturers, including nasal masks, full-face masks, nasal pillows, nasal sprays, and oronasal masks.
[0043] A seal-forming structure that is effective in one area of a patient's face may not be suitable in another area, for example, because of the different shapes, structures, variations, and sensitive areas of the patient's face. For example, a seal on swimming goggles that covers the patient's forehead may not be suitable for use on the patient's nose.
[0044] Certain seal-forming structures may be designed for mass manufacturing so that one design is appropriate, comfortable, and effective for a wide range of different face shapes and sizes. To the extent there is a mismatch between the shape of the patient's face and the seal-forming structure of a mass-manufactured patient interface, one or both must adapt to form a seal.
[0045] One type of seal-forming structure extends around the periphery of the patient interface and is used to seal against the patient's face when a force is applied to the patient interface while the seal-forming structure is in facing engagement with the patient's face. The seal-forming structure may include an air or fluid filled cushion, or a molded or formed surface of a resilient sealing element made of an elastomer (e.g., rubber). With this type of seal-forming structure, if the fit is inadequate, there will be a gap between the seal-forming portion and the face, and additional force will be required to force the patient interface against the face to achieve a seal.
[0046] Another type of seal-forming structure includes a flap seal of thin material positioned around the perimeter of the mask to provide a self-sealing action against the patient's face when positive pressure is applied within the mask. Similar to the previous forms of seal-forming portions, if the fit between the face and the mask is not good, additional force may be required to achieve a seal, or the mask may leak. In addition, if the shape of the seal-forming structure does not match the shape of the patient, it may wrinkle or bend during use, causing leaks.
[0047] Another type of seal-forming structure may include friction-fit elements, for example for insertion into a nostril, however some patients find these uncomfortable.
[0048] Another form of seal-forming structure may use an adhesive to achieve a seal. Some patients may find it inconvenient to constantly apply and remove adhesive from their face.
[0049] A series of patient interface seal forming structure technologies are disclosed in the following patent applications assigned to ResMed Limited: WO 1998 / 004,310; WO 2006 / 074,513; WO 2010 / 135,785.
[0050] One form of nasal pillow is found in the Adam Circuit manufactured by Puritan Bennett. Another nasal pillow or nasal spray is the subject of U.S. Patent 4,782,832 (Trimble et al.), assigned to Puritan-Bennett Corporation.
[0051] ResMed Inc. already manufactures the following products in combination with nasal pillows: SWIFT TM Nasal pillow mask, SWIFT TM II nasal pillow mask, SWIFT TM LT nasal pillow mask, SWIFT TM FX Nasal Pillows Mask and MIRAGE LIBERTY TMFull face mask. The following patent applications assigned to ResMed Ltd. describe examples of nasal pillow masks: International Patent Application WO 2004 / 073,778 (which describes the ResMed Ltd. SWIFT TM Other aspects of nasal pillows); U.S. Patent Application 2009 / 0044808 (which describes ResMed Inc. SWIFT TM LT nasal pillows); International Patent Applications WO 2005 / 063,328 and WO 2006 / 130,903 (which describe MIRAGE LIBERTY TM Other aspects of full-face masks); International patent application WO 2009 / 052,560 (which describes the SWIFT TM Other aspects of the FX nasal pillows).
[0052] 2.2.3.1.2 Positioning and stabilization
[0053] The seal-forming structure of the patient interface for positive air pressure therapy is subjected to the corresponding force of air pressure to break the seal. Therefore, various techniques have been used to position the seal-forming structure and maintain it in a sealing relationship with the appropriate part of the face.
[0054] One technique is to use an adhesive. See, for example, U.S. Patent Application Publication No. US2010 / 0000534. However, the use of an adhesive may be uncomfortable for some people.
[0055] Another technique is to use one or more straps and / or stabilizing harnesses.Many such harnesses suffer from one or more of poor fit, bulk, discomfort, and awkward use.
[0056] 2.2.3.2 Respiratory Pressure Therapy (RPT) Devices
[0057] Respiratory pressure therapy (RPT) devices can be used alone or as part of a system to deliver one or more of the above-mentioned therapies, such as by operating the device to generate an airflow for delivery to an airway interface. The air flow can be pressurized. Examples of RPT devices include CPAP devices and ventilators.
[0058] Air pressure generators are known in a range of applications, such as industrial-scale ventilation systems. However, air pressure generators for medical applications have specific requirements that are not met by more general air pressure generators, such as reliability, size and weight requirements for medical devices. Furthermore, even devices designed for medical use may have disadvantages with respect to one or more of the following: comfort, noise, ease of use, efficacy, size, weight, manufacturability, cost and reliability.
[0059] An example of a special requirement for certain RPT devices is noise.
[0060] Table of noise output levels of existing RPT devices (one sample only, measured at 10 cmH2O in CPAP mode using the test method specified in ISO 3744).
[0061] RPT device name A-weighted sound pressure level dB(A) Year(approx.) <![CDATA[C-Series Tango TM > 31.9 2007 <![CDATA[C-Series Tango with Humidifier TM > 33.1 2007 <![CDATA[S8 Escape TM II]]> 30.5 2005 <![CDATA[With H4i TM S8 Escape of the humidifier TM II]]> 31.1 2005 <![CDATA[S9 AutoSet TM ]]> 26.5 2010 <![CDATA[With H5i TM S9 AutoSet of humidifier TM > 28.6 2010
[0062] One known RPT device for treating sleep apnea is the S9 sleep therapy system manufactured by ResMed Limited. Another example of an RPT device is a ventilator. TM The ventilator in the range of adult and pediatric ventilators can provide support for invasive and non-invasive non-dependent ventilation to a range of patients for the treatment of a variety of conditions such as, but not limited to, NMD, OHS and COPD.
[0063] ResMed Elisée TM 150 ventilator and ResMed VS III TM Ventilators can provide support for invasive and non-invasive dependent ventilation suitable for adult or pediatric patients for the treatment of a variety of diseases. These ventilators provide volume and air pressure ventilation modes with single or dual channel circuits. RPT devices typically include a pressure generator, such as an electric blower or a compressed gas reservoir, and are configured to supply an air flow to the patient's airway. In some cases, the air flow can be supplied to the patient's airway under positive pressure. The outlet of the RPT device is connected to a patient interface such as described above via an air circuit.
[0064] The designer of the device may be provided with an infinite number of choices that can be made. Design criteria often conflict, which means that some design choices are far from conventional or unavoidable. In addition, some aspects of comfort and efficacy may be highly sensitive to small and subtle changes in one or more parameters.
[0065] 2.2.3.3 Humidifier
[0066] Delivering an air stream without humidification may result in airway drying. Using a humidifier with an RPT device and a patient interface produces humidified gas that minimizes drying of the nasal mucosa and increases patient airway comfort. Additionally, in colder climates, warm air typically applied to the facial area in and around the patient interface is more comfortable than cold air.
[0067] A range of artificial humidification devices and systems are known, however they may not meet the specific requirements of a medical humidifier.
[0068] Medical humidifiers are used to increase the humidity and / or temperature of an air stream relative to ambient air when needed, typically where a patient may be asleep or resting (e.g., in a hospital). Medical humidifiers for bedside placement can be very small. Medical humidifiers can be configured to only humidify and / or heat the air stream delivered to the patient, without humidifying and / or heating the patient's surroundings. Room-based systems (e.g., saunas, air conditioners, or evaporative coolers), for example, can also humidify the air that the patient breathes, but these systems also humidify and / or heat the entire room, which may cause discomfort to the occupants. In addition, medical humidifiers may have more stringent safety restrictions than industrial humidifiers.
[0069] Although many medical humidifiers are known, they may have one or more disadvantages. Some medical humidifiers may provide inadequate humidification, and some may be difficult or inconvenient to use by patients.
[0070] 2.2.3.4 Data Management
[0071] There may be many clinical reasons to obtain data to determine whether a patient being treated with a prescribed respiratory therapy is "compliant," such as if the patient has used their RPT device in accordance with one or more "compliance rules." One example of a compliance rule for CPAP therapy is a requirement that the patient use the RPT device for at least four hours each night for at least 21 or 30 consecutive days in order for the patient to comply. To determine the patient's compliance, a provider of the RPT device, such as a health care provider, may manually obtain data describing the use of the RPT device for the patient's treatment, calculate usage over a predetermined time period and compare to the compliance rules. Once the health care provider has determined that the patient has used their RPT device in accordance with the compliance criteria, the health care provider may inform the patient of the third part of compliance.
[0072] There are other aspects of patient treatment that may benefit from communication of treatment data to a third party or external system.
[0073] Existing methods of communicating and managing such data can be one or more of the following: expensive, time consuming, and error prone.
[0074] 2.2.3.5 Mandibular reduction
[0075] A mandibular repositioning device (MRD) or mandibular advancement device (MAD) is one of the treatment options for sleep apnea and snoring. It is an adjustable oral appliance available from a dentist or other supplier that holds the mandible (lower jaw) in a forward position during sleep. An MRD is a removable device that the patient inserts into their mouth before falling asleep and removes after sleep. Therefore, an MRD is not designed to be worn all the time. MRDs can be custom made or produced in a standard form and include a bite impression portion designed to allow fit to the patient's teeth. This mechanical protrusion of the mandible expands the space behind the tongue, exerts tension on the pharyngeal walls to reduce collapse of the airway and reduce vibrations of the palate.
[0076] In some examples, the mandibular advancement device may include an upper splint intended to engage or cooperate with teeth on the upper jaw or maxilla and a lower splint intended to engage or cooperate with teeth on the upper jaw or mandible. The upper splint and the lower splint are laterally connected together by a pair of connecting rods. The pair of connecting rods are symmetrically fixed to the upper splint and the lower splint.
[0077] In this design, the length of the connecting rod is selected so that when the MRD is placed in the patient's mouth, the mandible remains in an anteriorly displaced position. The length of the connecting rod can be adjusted to change the degree of protrusion of the mandible. The dentist can determine the degree of protrusion of the mandible, which will determine the length of the connecting rod.
[0078] Some MRDs are constructed to push the mandible forward relative to the maxilla, while other MADs (e.g., ResMed Narval CC TM The MRD) is designed to hold the mandible in a forward position. The device also reduces or minimizes dental and temporomandibular joint (TMJ) side effects. Therefore, it is configured to minimize or prevent any movement of one or more teeth.
[0079] 2.2.3.6 Ventilation technology
[0080] Some forms of patient interface systems may include a vent to allow flushing of exhaled carbon dioxide. The vent may allow gas to flow from an interior space (eg, a plenum) of the patient interface to a space outside the patient interface, such as to the environment.
[0081] The vent may include an orifice through which gas may flow when the mask is used. Many such vents are noisy. Others may become blocked when in use, thereby providing insufficient flushing. Some vents may disrupt the sleep of the patient's 1000 bed partner 1100, for example by making noise or by gathering airflow.
[0082] ResMed Inc. has developed many improved mask ventilation technologies. See, for example, International Patent Application Publication No. WO 1998 / 034,665; International Patent Application Publication No. WO 2000 / 078,381; U.S. Patent No. 6,581,594; U.S. Patent Application Publication No. US2009 / 0050156; U.S. Patent Application Publication No. 2009 / 0044808.
[0083] Noise table of existing masks (ISO 17510-2:2007, pressure of 10cmH2O at 1m)
[0084]
[0085]
[0086] (*One sample only, measured at 10 cmH2O in CPAP mode using the test method specified in ISO 3744)
[0087] The following lists the sound pressure values of various objects
[0088]
[0089] 2.2.4 Screening, diagnosis and monitoring systems
[0090] Polysomnography (PSG) is a conventional system for diagnosing and monitoring cardiopulmonary diseases, and usually involves professional clinical medical staff who apply the system. PSG usually involves placing 15 to 20 contact sensors on the patient to record various body signals, such as electroencephalogram (EEG), electrocardiogram (ECG), electrooculogram (EOG), electromyogram (EMG), etc. PSG for sleep apnea has involved two nights of observation of the patient in the clinic, i.e. one night of pure diagnosis and the second night when the treatment parameters are determined by the clinician. PSG is therefore expensive and inconvenient. In particular, it is not suitable for home screening / diagnosis / monitoring of sleep apnea.
[0091] Screening and diagnosis generally describe the identification of a condition from its signs and symptoms. Screening typically gives a true / false result indicating whether a patient's SDB is severe enough to warrant further investigation, while diagnosis can yield clinically actionable information. Screening and diagnosis tend to be a one-time process, while monitoring the progression of a condition can continue indefinitely. Some screening / diagnostic systems are only for screening / diagnosis, while some can also be used for monitoring.
[0092] Clinical experts can appropriately screen, diagnose or monitor patients based on visual observation of PSG signals. However, there are situations where clinical experts may not be available or clinical experts may not be affordable. Different clinical experts may disagree on a patient's condition. In addition, a given clinical expert may apply different criteria at different times. Summary of the invention
[0093] The present technology is intended to provide a medical device for screening, diagnosing, monitoring, ameliorating, treating or preventing respiratory disorders with improved one or more of comfort, cost, efficacy, ease of use and manufacturability.
[0094] A first aspect of the present technology relates to a device for screening, diagnosing, monitoring, ameliorating, treating or preventing a respiratory disorder.
[0095] Another aspect of the present technology relates to methods for screening, diagnosing, monitoring, ameliorating, treating or preventing breathing disorders.
[0096] One aspect of some forms of the present technology is to provide methods and / or apparatus for improving patient compliance with respiratory therapy.
[0097] Another aspect of the present technology relates to a patient interface comprising: an inflatable chamber that is capable of being pressurized to a therapeutic pressure of at least 6 cmH2O above ambient air pressure, the inflatable chamber including a inlet port of the inflatable chamber, the inlet port of the inflatable chamber being sized and configured to receive a flow of air at the therapeutic pressure for patient breathing; a seal-forming structure that is constructed and arranged to seal an area of the patient's face surrounding an entrance to the patient's airway, the seal-forming structure having an aperture therein so that the flow of air at the therapeutic pressure is delivered to at least one entrance to the patient's nostrils, the seal-forming structure being constructed and arranged to maintain the therapeutic pressure in the inflatable chamber throughout the patient's breathing cycle in use; a positioning and stabilizing structure that provides a force To maintain the seal-forming structure in a therapeutically effective position on the patient's head, the positioning and stabilizing structure includes a strap, the strap being constructed and arranged so that when in use, at least a portion covers an area of the patient's head above a base point above the patient's ears; and a vent structure, the vent structure allowing gas exhaled by the patient to flow continuously from the interior of the inflatable chamber to the surrounding environment, the size and shape of the vent structure being set to maintain a therapeutic pressure in the inflatable chamber during use, wherein the patient interface is configured so that the patient's mouth is not covered, or if the seal-forming structure is configured to seal around the patient's nose and mouth, the patient interface is configured to allow the patient to breathe from the surrounding environment without pressurized air flowing through the inlet port of the inflatable chamber.
[0098] Another aspect of the present technology relates to a CPAP system for providing positive pressure gas for respiratory therapy to a patient. The CPAP system includes an RPT device configured to provide a flow of gas at a therapeutic pressure, a patient interface that forms an inflatable chamber that can be pressurized to a therapeutic pressure, the patient interface including a seal-forming structure that is constructed and arranged to form a seal with an area of the patient's face surrounding the patient's airway entrance, an air delivery conduit configured to convey a gas flow at a therapeutic pressure from the RPT device to the patient interface, and a ventilation assembly configured to provide a ventilation flow of gas to exhaust gas exhaled by the patient from a pressurized volume into the surrounding environment. The ventilation assembly includes a base, the base including at least one first orifice extending through the base to allow gas to be exhausted from the pressurized volume to the surrounding environment along a primary ventilation flow path, at least one second orifice that allows gas to be exhausted from the pressurized volume to the surrounding environment along an auxiliary ventilation flow path, a diffusion member disposed on the base, and a membrane disposed on the base. The diffuser member is configured and arranged such that at least one first aperture is covered by the diffuser member such that ventilation flow passes through the diffuser member along a primary ventilation flow path, and at least one second aperture is not covered by the diffuser member such that ventilation flow bypasses the diffuser member along an auxiliary ventilation flow path. The membrane is constructed and arranged for distributing ventilation flow of gas along the primary ventilation flow path and the auxiliary ventilation flow path throughout a respiratory therapy procedure.
[0099] Another aspect of the present technology relates to a CPAP system for providing positive pressure gas for respiratory therapy to a patient. The CPAP system includes a RPT device configured to provide a flow of gas at a therapeutic pressure, a patient interface forming a plenum chamber that can be pressurized to a therapeutic pressure, the patient interface including a seal-forming structure, the seal-forming structure constructed and arranged to form a seal with an area of the patient's face surrounding the patient's airway entrance, an air delivery conduit configured to convey a gas flow at a therapeutic pressure from the RPT device to the patient interface, and a ventilation assembly configured to provide a gas ventilation flow to exhaust gas exhaled by the patient from a pressurized volume into an ambient environment. The ventilation assembly includes a base, the base including at least one first orifice extending through the base to allow gas to be exhausted from the pressurized volume to the ambient environment along a primary ventilation flow path, at least one second orifice allowing gas to be exhausted from the pressurized volume to the ambient environment along an auxiliary ventilation flow path, a diffusion member disposed on the base, and a ventilation component disposed at least one second orifice of the base, the ventilation component including a plurality of ventilation orifices. The diffuser member is configured and arranged such that at least one first orifice is covered by the diffuser member along a primary ventilation flow path and at least one second orifice is not covered by the diffuser member along an auxiliary ventilation flow path. The ventilator component includes an expanded polymer material constructed and arranged for regulating ventilation flow of gas along the auxiliary ventilation flow path throughout respiratory therapy.
[0100] Another aspect of the present technology relates to a CPAP system for providing positive pressure gas for respiratory therapy to a patient. The CPAP system includes an RPT device configured to provide a flow of gas at a therapeutic pressure, a patient interface that forms an inflatable chamber that can be pressurized to a therapeutic pressure, the patient interface including a seal-forming structure, the seal-forming structure constructed and arranged to form a seal with an area of the patient's face surrounding the patient's airway entrance, an air delivery conduit configured to convey a gas flow at a therapeutic pressure from the RPT device to the patient interface, and a ventilation assembly configured to provide a gas ventilation flow to exhaust gas exhaled by the patient from the pressurized volume to the surrounding environment. The ventilation assembly includes a ventilation member, a diffusion member, and a support structure, the ventilation member including a fabric material and a plurality of ventilation holes that allow gas to be exhausted from the pressurized volume to the surrounding environment, the diffusion member including a fabric material and configured and arranged so that the plurality of ventilation holes are covered by the diffusion member, and the support structure supports the diffusion member in a spaced relationship with the ventilation member. The support structure includes openings that allow gas to be discharged along a main ventilation flow path and lateral openings that allow gas to be discharged along an auxiliary ventilation flow path, and the diffusion member is supported by the support structure so that the openings are covered by the diffusion member so that the ventilation flow passes through the diffusion member along the main ventilation flow path, and the lateral openings are not covered by the diffusion member so that the ventilation flow bypasses the diffusion member along the auxiliary ventilation flow path.
[0101] Another aspect of the present technology relates to a vent assembly that includes a base, a diffuser member, a membrane, and / or a vent component.
[0102] Another aspect of the present technology relates to a vent assembly that includes a base that includes at least one first orifice extending through the base to allow gas to be discharged from a pressurized volume along a primary ventilation flow path into a surrounding environment, at least one second orifice that allows gas to be discharged from the pressurized volume along an auxiliary ventilation flow path into a surrounding environment, a diffusion member disposed on the base, and a membrane disposed on the base. The diffusion member is configured and arranged such that at least one first orifice is covered by the diffusion member such that ventilation flow passes through the diffusion member along the primary ventilation flow path, and at least one second orifice is not covered by the diffusion member such that ventilation flow bypasses the diffusion member along the auxiliary ventilation flow path. The membrane is constructed and arranged to distribute the ventilation flow of gas along the primary ventilation flow path and the auxiliary ventilation flow path throughout a respiratory therapy session.
[0103] Another aspect of the present technology relates to a vent assembly comprising a base, the base comprising at least one first orifice extending through the base to allow gas to be discharged from a pressurized volume into an ambient environment along a primary ventilation flow path, at least one second orifice allowing gas to be discharged from the pressurized volume into an ambient environment along an auxiliary ventilation flow path, a diffusion member disposed on the base, and a vent component disposed at least one second orifice of the base, the vent component comprising a plurality of vent orifices. The diffusion member is configured and arranged such that at least one first orifice is covered by the diffusion member along the primary ventilation flow path and at least one second orifice is not covered by the diffusion member along the auxiliary ventilation flow path. The vent component comprises an expanded polymer material constructed and arranged to regulate a ventilation flow of gas along the auxiliary ventilation flow path throughout a respiratory therapy session.
[0104]
[0013] Another aspect of the present technology relates to a vent assembly that includes a fabric vent member, a fabric diffuser member, and / or a support structure.
[0105] Another aspect of the present technology relates to a vent assembly including a vent member, a diffuser member, and a support structure, the vent member including a fabric material and including a plurality of vent holes that allow gas to vent from a pressurized volume to an ambient environment, the diffuser member including a fabric material and configured and arranged such that the plurality of vent holes are covered by the diffuser member, the support structure supporting the diffuser member in a spaced relationship with the vent member, the support structure including an opening that allows gas to vent along a primary vent flow path and a lateral opening that allows gas to vent along an auxiliary vent flow path, and the diffuser member being supported by the support structure such that the opening is covered by the diffuser member such that a vent flow passes through the diffuser member along the primary vent flow path, and the lateral opening is not covered by the diffuser member such that a vent flow bypasses the diffuser member along the auxiliary vent flow path.
[0106] Another aspect of the present technology relates to a ventilation assembly configured to provide a ventilation flow of gas to discharge gas from a pressurized volume to a surrounding environment. The ventilation assembly includes at least one first orifice to allow gas to be discharged from the pressurized volume to the surrounding environment along a primary ventilation flow path, at least one second orifice to allow gas to be discharged from the pressurized volume to the surrounding environment along an auxiliary ventilation flow path, a diffusion member, which is configured and arranged so that at least one first orifice is covered by the diffusion member so that ventilation flow passes through the diffusion member along the primary ventilation flow path, and at least one second orifice is not covered by the diffusion member so that the ventilation flow bypasses the diffusion member along the auxiliary ventilation flow path, and a diaphragm, which is constructed and configured to distribute the ventilation flow of gas along the primary ventilation flow path and the auxiliary ventilation flow path. In one example, the ventilation assembly is provided with a patient interface. In one example, the ventilation assembly is provided with an air delivery conduit.
[0107] One aspect of some forms of the present technology is a medical device that is easy to use, such as by individuals without medical training, individuals with limited dexterity, vision, or individuals with limited experience using medical devices of this type.
[0108] One aspect of one form of the present technology is a patient interface that can be cleaned in the patient's home (eg, in soapy water) without the need for specialized cleaning equipment.
[0109] Of course, parts of various aspects can form sub-aspects of the technology of the present invention. In addition, each of the sub-aspects and / or aspects can be combined in various ways and also constitute additional aspects or sub-aspects of the technology.
[0110] Other features of the inventive technology will become apparent by considering the information contained in the following detailed description, abstract, drawings, and claims. BRIEF DESCRIPTION OF THE DRAWINGS
[0111] The present technology is illustrated by way of example and not limitation in the figures of the accompanying drawings in which like reference numerals refer to similar elements, including:
[0112] 4.1 Treatment system
[0113] Figure 1A A system is shown that includes a patient 1000 wearing a patient interface 3000 in the form of nasal pillows receiving a positive pressure supply of air from a RPT device 4000. Air from the RPT device 4000 is humidified in a humidifier 5000 and delivered to the patient 1000 along an air circuit 4170. A bed partner 1100 is also shown. The patient sleeps in a supine position.
[0114] Figure 1B A system is shown that includes a patient 1000 wearing a patient interface 3000 in the manner of a nasal mask receiving a supply of air at a positive pressure from a RPT device 4000. Air from the RPT device is humidified in a humidifier 5000 and delivered to the patient 1000 along an air circuit 4170.
[0115] Figure 1C A system is shown that includes a patient 1000 wearing a patient interface 3000 in the form of a full face mask, receiving a supply of air at a positive pressure from a RPT device 4000. Air from the RPT device is humidified in a humidifier 5000 and delivered to the patient 1000 along an air circuit 4170. The patient sleeps in a side-lying position.
[0116] 4.2 Respiratory system and facial anatomy
[0117] Figure 2AA schematic diagram of the human respiratory system including the nasal and oral cavities, larynx, vocal cords, esophagus, trachea, bronchi, lungs, alveolar sacs, heart, and diaphragm is shown.
[0118] Figure 2B A view of the human upper airway including the nasal cavity, nasal bones, external nasal cartilages, greater alar cartilages, nostrils, upper lip, lower lip, larynx, hard palate, soft palate, oropharynx, tongue, epiglottis, vocal cords, esophagus, and trachea is shown.
[0119] Figure 2C is a front view of the face with several surface anatomical features identified, including the upper lip, upper lip vermilion, lower lip vermilion, lower lip, mouth width, medial canthus, nasal wing, nasolabial fold, and corner of mouth. The superior, inferior, radially inward, and radially outward directions are also indicated.
[0120] Figure 2D It is a side view of the head with several surface anatomical features labeled, including the brow, nasal bridge point, nasal prominence point, nasal septum subpoint, upper lip, lower lip, mandibular alveolar seat point, nasal bridge, nose wing apex, subauricular base point, and supraauricular base point. The up-down and anterior-posterior directions are also labeled.
[0121] Figure 2E This is another lateral view of the head. The approximate locations of the Frankfurt plane and nasolabial angle are indicated. The coronal plane is also indicated.
[0122] Figure 2F A bottom view of the nose is shown with several features identified, including the nasolabial folds, lower lip, vermillion, nostrils, subseptal point, columella, nasal process point, long axis of the nostrils, and the midsagittal plane.
[0123] Figure 2G A side view of the nasal surface features is shown.
[0124] Figure 2H The subcutaneous structures of the nose are shown, including the lateral cartilage, septal cartilage, greater alar cartilage, lesser alar cartilage, sesamoid cartilage, nasal bone, epidermis, adipose tissue, frontal process of the maxilla, and fibroadipose tissue.
[0125] Fig.2I The medial anatomy of the nose is shown approximately a few millimeters from the mid-sagittal plane, showing, among other things, the medial crus of the septal cartilage and the greater alar cartilage.
[0126] Figure 2J A frontal view of the skull is shown, including the frontal, nasal, and zygomatic bones. The nasal turbinates are also labeled, as are the maxilla and mandible.
[0127] Figure 2KA side view of the skull with the outline of the head surface and several muscles is shown. The following bones are shown: frontal, sphenoid, nasal, zygomatic, maxillary, mandibular, parietal, temporal, and occipital. The mental protuberance is also labeled. The following muscles are shown: digastric, masseter, sternocleidomastoid, and trapezius.
[0128] Figure 2L An anterolateral view of the nose is shown.
[0129] 4.3 Patient Interface
[0130] Figure 3A A patient interface in the form of a nasal mask is shown in accordance with one form of the present technology.
[0131] Figure 3B A schematic diagram of a cross section through the structure at a point is shown. The outward normal at that point is indicated. The curvature at that point has a positive sign and is Figure 3C The curvature magnitude shown is relatively large in comparison.
[0132] Figure 3C A schematic diagram of a cross section through the structure at a point is shown. The outward normal at that point is indicated. The curvature at that point has a positive sign and is Figure 3B The curvature magnitude shown is relatively small in comparison.
[0133] Figure 3D A schematic diagram of a cross section through the structure at a point is shown. The outward normal at that point is indicated. The curvature at that point has a value of zero.
[0134] Figure 3E A schematic diagram of a cross section through the structure at a point is shown. The outward normal at that point is indicated. The curvature at that point has a negative sign and is Figure 3F The curvature magnitude shown is relatively small in comparison.
[0135] Figure 3F A schematic diagram of a cross section through the structure at a point is shown. The outward normal at that point is indicated. The curvature at that point has a negative sign and is Figure 3E The curvature magnitude shown is relatively large in comparison.
[0136] Figure 3G A cushion for a mask comprising two pillows is shown. The outer surface of the cushion is indicated. The edges of the surface are indicated. The dome area and the saddle area are indicated.
[0137] Figure 3HA cushion for a face mask is shown. The outer surface of the cushion is indicated. The edge of the surface is indicated. The path on the surface between point A and point B is indicated. The straight-line distance between point A and point B is indicated. Two saddle regions and one dome region are indicated.
[0138] Fig. 3I A surface of a structure is shown, wherein the surface has a one-dimensional hole in it. The plane curves shown form the boundaries of the one-dimensional hole.
[0139] Figure 3J Shown by Fig. 3I The surface shown defines Fig. 3I A 2D hole in a structure.
[0140] Figure 3K Show Fig. 3I A perspective view of a structure including two-dimensional holes and one-dimensional holes. Also shown is a definition Fig. 3I The surface of a two-dimensional hole in a structure.
[0141] Figure 3L A mask with an inflatable bladder as a cushion is shown.
[0142] Figure 3M Shown by Figure 3L A cross section of a mask and showing the inner surface of the airbag. The inner surface defining the two-dimensional hole in the mask.
[0143] Figure 3N Shown through Figure 3L Another cross section of a mask of FIG. The inner surface is also indicated.
[0144] Fig.3O The left-hand rule is shown.
[0145] Figure 3P The right-hand rule is shown.
[0146] Figure 3Q The left ear is shown, including the left ear helix.
[0147] Figure 3R The right ear is shown, including the right ear helix.
[0148] Figure 3S A right-hand helix is shown.
[0149] Figure 3T A view of a mask is shown including torsion signatures of a spatial curve defined by the edge of the sealing membrane in different regions of the mask.
[0150] Figure 3U A view of the plenum chamber 3200 is shown, showing the sagittal plane and the medial contact plane.
[0151] Figure 3V Shows Figure 3U View of the rear of the plenum chamber. The direction of view is perpendicular to the median contact plane. Figure 3V The sagittal plane divides the air chamber into left-hand and right-hand sides.
[0152] Figure 3W Shown through Figure 3V The cross section of the gas-filled chamber is taken from Figure 3V The sagittal plane is shown. A "mid-contact" plane is shown. The mid-contact plane is perpendicular to the sagittal plane. The orientation of the mid-contact plane corresponds to the orientation of the chord 3210, which lies in the sagittal plane and contacts the cushion of the plenum at two points exactly in the sagittal plane: the upper point 3220 and the lower point 3230. Depending on the geometry of the cushion in the area, the mid-contact plane can be tangent at both the upper point and the lower point.
[0153] Figure 3X Shows Figure 3U The inflatable chamber 3200 is in the position of use on the face. When the inflatable chamber is in the use position, the sagittal plane of the inflatable chamber 3200 generally coincides with the central sagittal plane of the face. When the inflatable chamber is in the use position, the median contact plane generally corresponds to the "plane of the face". Figure 3X In FIG. 3 , the inflation chamber 3200 is the inflation chamber of the nasal mask, and the upper point 3220 is approximately located on the bridge of the nose, while the lower point 3230 is located on the upper lip.
[0154] 4.4 Ventilation components
[0155] Figure 4A is a perspective view of a ventilation assembly configured to an air delivery conduit in accordance with an example of the present technology.
[0156] Figure 4B is a cross-sectional view of a ventilation assembly configured to an air delivery conduit in accordance with an example of the present technology.
[0157] Figure 4C is an exploded view of a ventilation assembly and air delivery conduit according to an example of the present technology.
[0158] Figure 4D is another exploded view of a ventilation assembly and air delivery conduit according to an example of the present technology.
[0159] Figure 4E Depicted is a perspective view of a vent assembly according to one example of the present technology.
[0160] Figure 4F yes Figure 4E A cross-sectional view of a ventilation assembly.
[0161] Figure 4G yes Figure 4E Exploded view of the vent assembly.
[0162] Figure 4H yes Figure 4E Another exploded view of the vent assembly.
[0163] Fig. 4I is an example showing that, according to the present technology, when there is no air pressure or low pressure in the air delivery duct and the fabric material is not blocked, air passes through Figure 4E A cross-sectional view of a ventilation assembly.
[0164] Figure 4J is an example of the present technology showing that when there is air pressure in the air delivery duct and the fabric material is not blocked, air passes through Figure 4E A cross-sectional view of a ventilation assembly.
[0165] Figure 4K is an example of the present technology showing that when there is air pressure in the air delivery duct and the fabric material is blocked, air passes through Figure 4E A cross-sectional view of a ventilation assembly.
[0166] Figure 5A A perspective view of a vent assembly according to an example of the present technology is shown.
[0167] Figure 5B yes Figure 5A A cross-sectional view of a ventilation assembly.
[0168] Figure 5C yes Figure 5A Exploded view of the vent assembly.
[0169] Figure 5D yes Figure 5A Another exploded view of the vent assembly.
[0170] Figure 5E is an example showing that, according to the present technology, when there is no air pressure or low pressure in the air delivery duct and the fabric material is not blocked, air passes through Figure 5A A cross-sectional view of a ventilation assembly.
[0171] Fig. 5F is an example of the present technology showing that when there is air pressure in the air delivery duct and the fabric material is not blocked, air passes through Figure 5A A cross-sectional view of a ventilation assembly.
[0172] Figure 5G is an example of the present technology, when there is air pressure in the air delivery conduit and the fabric material is blocked, passing through Figure 5A A cross-sectional view of the air vent assembly.
[0173] Fig. 6Ais a perspective view of a ventilation assembly configured to an air delivery conduit in accordance with an example of the present technology.
[0174] Figure 6B is a cross-sectional view of a ventilation assembly configured to an air delivery conduit in accordance with an example of the present technology.
[0175] Figure 6C is an exploded view of a ventilation assembly and air delivery conduit according to an example of the present technology.
[0176] Fig.6D is another exploded view of a ventilation assembly and air delivery conduit according to an example of the present technology.
[0177] Fig. 6E Depicted is a perspective view of a vent assembly according to one example of the present technology.
[0178] Fig. 6F yes Fig. 6E A cross-sectional view of a ventilation assembly.
[0179] Figure 6G yes Fig. 6E Exploded view of the vent assembly.
[0180] Figure 6H yes Fig. 6E Another exploded view of the vent assembly.
[0181] Fig.6I is an example showing that, according to the present technology, when there is no air pressure or low pressure in the air delivery duct and the fabric material is not blocked, air passes through Fig. 6E A cross-sectional view of a ventilation assembly.
[0182] Figure 6J is an example of the present technology showing that when there is air pressure in the air delivery duct and the fabric material is not blocked, air passes through Fig. 6E A cross-sectional view of a ventilation assembly.
[0183] Figure 6K is an example of the present technology showing that when there is air pressure in the air delivery duct and the fabric material is blocked, air passes through Fig. 6E A cross-sectional view of a ventilation assembly.
[0184] Fig. 7A An exploded view of a vent assembly according to one example of the present technology is shown.
[0185] Figure 7B yes Fig. 7A Another exploded view of the vent assembly.
[0186] Figure 7C yes Fig. 7A A perspective view of the activators and sensors of the ventilation assembly.
[0187] Fig. 8A A perspective view of a vent assembly according to an example of the present technology is shown.
[0188] Figure 8B yes Fig. 8A A cross-sectional view of a ventilation assembly.
[0189] Figure 8C yes Fig. 8A Exploded view of the vent assembly.
[0190] Fig.8D is an example of the present technology showing that when there is air pressure in the air delivery duct and the fabric material is not blocked, air passes through Fig. 8A A cross-sectional view of a ventilation assembly.
[0191] Fig. 8E is an example of the present technology, when there is air pressure in the air delivery duct and the fabric material is blocked, passing through Fig. 8A A cross-sectional view of the air vent assembly.
[0192] Fig.9A A perspective view of a vent assembly according to an example of the present technology is shown.
[0193] Fig. 9B yes Fig.9A Bottom perspective view of the ventilation assembly.
[0194] Fig. 9C yes Fig.9A Exploded view of the vent assembly.
[0195] Fig.9D yes Fig.9A A cross-sectional view of a ventilation assembly.
[0196] Fig.9E FIG. 1 is a diagram showing air passing through the diffuser when there is air pressure and the diffuser member is not blocked according to an example of the present technology. Fig.9A A cross-sectional view of a ventilation assembly.
[0197] Fig.9F FIG. 1 is a diagram showing air passing through when there is air pressure and the diffuser member is blocked according to an example of the present technology. Fig.9A A cross-sectional view of a ventilation assembly.
[0198] Fig. 10A A perspective view of a vent assembly according to an example of the present technology is shown.
[0199] Fig. 10B yes Fig. 10A Bottom perspective view of the ventilation assembly.
[0200] Fig. 10C yes Fig. 10A Exploded view of the vent assembly.
[0201] Fig. 10D yes Fig. 10A A cross-sectional view of a ventilation assembly.
[0202] Fig. 10E FIG. 1 is a diagram showing air passing through the diffuser when there is air pressure and the diffuser member is not blocked according to an example of the present technology. Fig. 10A A cross-sectional view of a ventilation assembly.
[0203] Fig.10F FIG. 1 is a diagram showing air passing through when there is air pressure and the diffuser member is blocked according to an example of the present technology. Fig. 10A A cross-sectional view of a ventilation assembly.
[0204] Fig.11A is a graph illustrating exemplary vent flow through a vent assembly according to an example of the present technology.
[0205] Fig. 11B is a graph illustrating exemplary vent flow through a vent assembly according to an example of the present technology.
[0206] Fig. 11C is a graph illustrating exemplary vent flow through a vent assembly according to an example of the present technology.
[0207] Fig.11D is a graph illustrating exemplary vent flow through a vent assembly according to an example of the present technology.
[0208] Fig.11E is a graph illustrating exemplary vent flow through a vent assembly according to an example of the present technology.
[0209] Fig.11F is a graph illustrating exemplary vent flow through a vent assembly according to an example of the present technology. DETAILED DESCRIPTION
[0210] Before describing the present technology in more detail, it should be understood that the present technology is not limited to the specific examples described herein which may vary. It should also be understood that the terms used in the present invention are only used for the purpose of describing the specific examples discussed herein and are not intended to be limiting.
[0211] The following description is provided about various examples that can share one or more common characteristics and / or features. It should be understood that one or more features of any example can be combined with one or more features of another example or other examples. In addition, any single feature or combination of features in any example can constitute a further example.
[0212] 5.1 Treatment
[0213] In one form, the present technology includes a method for treating a breathing disorder, the method comprising the step of applying positive pressure to an airway entrance of a patient 1000 .
[0214] In certain examples of the present technology, a supply of air under positive pressure is provided to the patient's nasal passages via one or both nostrils.
[0215] In some examples of the present technology, mouth breathing is limited, restricted or prevented.
[0216] 5.2 Treatment system
[0217] In one form, the present technology includes an apparatus or device for treating a respiratory disorder. The apparatus or device may include an RPT device 4000 for supplying pressurized air to a patient 1000 via an air circuit 4170 leading to a patient interface 3000, e.g., see Figures 1A to 1C .
[0218] 5.3 Patient Interface
[0219] like Figure 3A As shown, a non-invasive patient interface 3000 according to one aspect of the present technology includes the following functional aspects: a seal-forming structure 3100, an inflatable chamber 3200, a positioning and stabilizing structure 3300, a vent 3400, a connection port 3600 for connecting to a form of air circuit 4170, and a forehead support 3700. In some forms, the functional aspects may be provided by one or more physical components. In some forms, one physical component may provide one or more functional aspects. When in use, the seal-forming structure 3100 is arranged to surround the entrance of the patient's airway so as to facilitate the supply of air under positive pressure to the airway.
[0220] If a patient interface is unable to comfortably deliver a minimum level of positive pressure to the airway, the patient interface may not be suitable for respiratory pressure therapy.
[0221] A patient interface 3000 in accordance with one form of the present technology is constructed and arranged to provide a supply of air at a positive pressure of at least 6 cmH2O relative to ambient.
[0222] A patient interface 3000 in accordance with one form of the present technology is constructed and arranged to provide a supply of air at a positive pressure of at least 10 cmH2O relative to ambient.
[0223] A patient interface 3000 in accordance with one form of the present technology is constructed and arranged to provide an air supply at a positive pressure of at least 20 cmH2O relative to ambient.
[0224] 5.3.1 Sealing structure
[0225] In one form of the present technology, the seal-forming structure 3100 provides a target seal-forming area and may additionally provide a cushioning function. The target seal-forming area is the area on the seal-forming structure 3100 where sealing is likely to occur. The area where sealing actually occurs - the actual sealing surface - may vary from day to day and from patient to patient during a given treatment period, depending on a number of factors, such as where the patient interface is placed on the face, the tension in the positioning and stabilizing structures, and the shape of the patient's face.
[0226] In one form, the target seal-forming area is located on an outer surface of the seal-forming structure 3100 .
[0227] In some forms of the present technology, the seal-forming structure 3100 is comprised of a biocompatible material, such as silicone rubber.
[0228] The seal-forming structure 3100 according to the present technology can be constructed of a soft, flexible and elastic material such as silicone.
[0229] In some forms of the present technology, a system is provided that includes more than one seal-forming structure 3100, each seal-forming structure 3100 configured to correspond to a different range of sizes and / or shapes. For example, the system may include one form of the seal-forming structure 3100 that is suitable for large-sized heads but not for small-sized heads, and another form that is suitable for small-sized heads but not for large-sized heads.
[0230] 5.3.1.1 Sealing mechanism
[0231] In one form, the seal forming structure includes a sealing flange that utilizes a pressure assisted sealing mechanism. In use, the sealing flange can easily respond to the system positive pressure inside the inflatable chamber 3200 acting on its bottom surface, so that it forms a tight sealing engagement with the face. The pressure assist mechanism can work together with the elastic tension in the positioning and stabilizing structure.
[0232] In one form, the seal forming structure 3100 includes a sealing flange and a support flange. The sealing flange includes a relatively thin member having a thickness of less than about 1 mm, such as about 0.25 mm to about 0.45 mm, which extends around the periphery of the plenum 3200. The support flange can be relatively thicker than the sealing flange. The support flange is disposed between the sealing flange and the edge of the plenum 3200 and extends at least a portion of the path around the periphery. The support flange is or includes a spring-like element and acts to support the sealing flange to prevent it from bending during use.
[0233] In one form, the seal forming structure may include a compression seal portion or a gasket seal portion. In use, the compression seal portion or the gasket seal portion is constructed and arranged to be in a compressed state, for example due to elastic tension in the positioning and stabilizing structure.
[0234] In one form, the seal-forming structure includes a tensioning portion that, when in use, maintains tension, for example, through an adjacent region of the sealing flange.
[0235] In one form, the seal-forming structure includes a region having a sticky or adhesive surface.
[0236] In certain forms of the present technology, the seal-forming structure may include one or more of a pressure-assisted sealing flange, a compression sealing portion, a gasket sealing portion, a tension portion, and a portion having a tacky or adhesive surface.
[0237] 5.3.1.2 Bridge of nose or nasal area
[0238] In one form, the non-invasive patient interface 3000 includes a seal-forming structure that forms a seal over a nasal bridge region or area of a patient's face when in use.
[0239] In one form, the seal-forming structure includes a saddle-shaped region configured to form a seal over a nasal bridge region or area of a patient's face in use.
[0240] 5.3.1.3 Upper lip area
[0241] In one form, the non-invasive patient interface 3000 includes a seal-forming structure, the seal-forming portion forming a seal on the upper lip region (ie, upper lip) of the patient's face when in use.
[0242] In one form, the seal-forming structure includes a saddle-shaped region configured to form a seal on an upper lip region of a patient's face in use.
[0243] 5.3.1.4 Chin area
[0244] In one form, the non-invasive patient interface 3000 includes a seal-forming structure which, in use, forms a seal over the chin region of the patient's face.
[0245] In one form, the seal-forming structure includes a saddle-shaped region configured to form a seal on a chin region of a patient's face in use.
[0246] 5.3.1.5 Forehead area
[0247] In one form, the seal-forming structure forms a seal on the forehead area of the patient's face when in use. In this form, the inflatable chamber can cover the eyes when in use.
[0248] 5.3.1.6 Nasal pillows
[0249] In one form, the seal-forming structure of the non-invasive patient interface 3000 comprises a pair of nasal puffs or pillows, each of which is constructed and arranged to form a seal with a corresponding nostril of the patient's nose.
[0250] A nasal pillow according to one aspect of the present technology includes: a frustoconical body, at least a portion of which forms a seal on the bottom surface of the patient's nose; a stem; and a flexible region on the bottom surface of the frustoconical body and connecting the frustoconical body to the stem. In addition, the structure to which the nasal pillows of the present technology are connected includes a flexible region adjacent to the bottom of the stem. The flexible region can work together to facilitate a universal engagement structure that can adapt to relative movement of both displacement and angle between the frustoconical body and the structure to which the nasal pillows are connected. For example, the position of the frustoconical body can be moved axially toward the structure to which the stem is connected.
[0251] 5.3.2 Inflatable chamber
[0252] In the area where the seal is formed in use, the plenum 3200 has a perimeter that is shaped complementary to the surface contour of an average human face. In use, the boundary edge of the plenum 3200 is in close proximity to the adjacent surface of the face. Actual contact with the face is provided by the seal-forming structure 3100. The seal-forming structure 3100 may extend along the entire perimeter of the plenum 3200 in use. In some forms, the plenum 3200 and the seal-forming structure 3100 are formed from a single uniform piece of material.
[0253] In some forms of the present technology, the inflatable chamber 3200 does not cover the patient's eyes when in use. In other words, the eyes are outside the pressurized volume defined by the inflatable chamber. Such forms tend to be less obtrusive and / or more comfortable to the wearer, which can improve compliance with treatment.
[0254] In some forms of the present technology, the plenum chamber 3200 is constructed of a transparent material, such as clear polycarbonate. The use of a transparent material can reduce the obtrusiveness of the patient interface and help improve compliance with treatment. The use of a transparent material can help the clinician observe how the patient interface is positioned and functioning.
[0255] In some forms of the present technology, the plenum chamber 3200 is constructed of a translucent material. The use of a translucent material can reduce the obtrusiveness of the patient interface and help improve compliance with therapy.
[0256] 5.3.3 Positioning and stabilizing the structure
[0257] The seal-forming structure 3100 of a patient interface 3000 of the present technology may be maintained in a sealed position during use by a positioning and stabilising structure 3300 .
[0258] In one form, the positioning and stabilising structure 3300 provides a retaining force that is at least sufficient to overcome the effect of the positive pressure in the plenum 3200 to lift off the face.
[0259] In one form, the positioning and stabilising structure 3300 provides a retaining force to overcome the effects of gravity on the patient interface 3000 .
[0260] In one form, the positioning and stabilising structure 3300 provides a retaining force as a safety margin to overcome the potentially damaging effects of forces acting on the patient interface 3000, such as from tube drag, or accidental interference with the patient interface.
[0261] In one form of the present technology, a positioning and stabilizing structure 3300 is provided that is configured in a manner consistent with being worn by a patient while sleeping. In one example, the positioning and stabilizing structure 3300 has a small side or cross-sectional thickness to reduce the sensed or actual volume of the instrument. In one example, the positioning and stabilizing structure 3300 includes at least one strap that is rectangular in cross-section. In one example, the positioning and stabilizing structure 3300 includes at least one flat strap.
[0262] In one form of the present technology, a positioning and stabilizing structure 3300 is provided that is configured so as not to be too large and bulky to prevent a patient from lying in a supine sleeping position with the posterior region of the patient's head resting on a pillow.
[0263] In one form of the present technology, a positioning and stabilizing structure 3300 is provided that is configured so as not to be too large and bulky to prevent a patient from lying in a side-lying sleeping position with the side region of the patient's head resting on a pillow.
[0264] In one form of the present technology, the positioning and stabilising structure 3300 is provided with a decoupling portion located between the front of the positioning and stabilising structure 3300 and the back of the positioning and stabilising structure 3300. The decoupling portion does not resist compression and may be, for example, a flexible strap or a floppy strap. The decoupling portion is constructed and arranged such that when the patient lies with the head on the pillow, the presence of the decoupling portion prevents forces acting on the back from being transmitted along the positioning and stabilising structure 3300 and breaking the seal.
[0265] In one form of the present technology, a positioning and stabilizing structure 3300 comprises a strap constructed from a laminate of a textile patient contacting layer, a foam inner layer, and a textile outer layer. In one form, the foam is porous to allow moisture (e.g., sweat) to pass through the strap. In one form, the textile outer layer comprises a loop material for engaging with a hook material portion.
[0266] In some forms of the present technology, the positioning and stabilizing structure 3300 includes a strap that is extendable, such as elastically extendable. For example, the strap can be configured to withstand tension during use and direct the force to seal the seal-forming structure to a portion of the patient's face. In one example, the strap can be configured as a tie.
[0267] In one form of the present technology, the positioning and stabilizing structure includes a first strap, which is constructed and arranged so that when in use, at least a portion of the lower edge of the first strap passes above the supra-auricular base of the patient's head and covers a portion of the parietal bone without covering the occipital bone.
[0268] In one form of the present technology applicable to a nasal mask only or a full-face mask, the positioning and stabilizing structure includes a second strap, which is constructed and arranged so that when in use, at least a portion of the upper edge of the second strap passes below the sub-ear base point of the patient's head and covers or is located below the occipital bone of the patient's head.
[0269] In one form of the present technology applicable to a nasal-only mask or a full-face mask, the positioning and stabilizing structure includes a third strap constructed and arranged to interconnect the first strap and the second strap to reduce the tendency of the first strap and the second strap to separate from each other.
[0270] In some forms of the present technology, the positioning and stabilizing structure 3300 comprises a strap that is flexible and, for example, non-rigid. An advantage of this aspect is that the strap makes it more comfortable for the patient to lie on while sleeping.
[0271] In some forms of the present technology, the positioning and stabilising structure 3300 comprises a strap configured to be breathable to allow moisture vapor to pass through the strap.
[0272] In some forms of the present technology, a system is provided that includes more than one positioning and stabilizing structure 3300, each positioning and stabilizing structure configured to provide a retention force corresponding to a different range of sizes and / or shapes. For example, the system may include one form of the positioning and stabilizing structure 3300 that is suitable for large sized heads but not for small sized heads, and another form that is suitable for small sized heads but not for large sized heads.
[0273] 5.3.4 Ventilation
[0274] In one form, the patient interface 3000 includes a vent 3400 constructed and arranged to allow flushing of exhaled gases, such as carbon dioxide.
[0275] In some forms, the vent 3400 is configured to allow a continuous flow of ventilation from the interior of the plenum chamber 3200 to the environment while the pressure within the plenum chamber is positive relative to the environment. The vent 3400 is configured to allow ventilation flow with sufficient rebreathing of CO2 exhaled by the patient while maintaining a therapeutic pressure in the plenum chamber when in use.
[0276] One form of vent 3400 in accordance with the present technology comprises a plurality of holes, for example, from about 20 to about 80 holes, or from about 40 to about 60 holes, or from about 45 to about 55 holes.
[0277] The vent 3400 may be located in the plenum chamber 3200. Alternatively, the vent 3400 is located in a decoupling structure such as a swivel.
[0278] Fabric ventilation components
[0279] Figures 4A to 4K A ventilation assembly 4400 is shown according to an example of the present technology, which is configured to provide a ventilation flow for exhausting gas exhaled by a patient. In the example shown, the ventilation assembly 4400 includes a diffusion member along the ventilation flow path, such as a layer of fabric material 4600, which is constructed and arranged to diffuse the exhaust ventilation flow to produce less noise.
[0280] Vents comprising fabric are very quiet and very discrete. However, when exposed to high humidity or water, fabric vents can significantly reduce ventilation flow. For example, ventilation flow may be partially or completely blocked due to water retention or due to condensation in the fabric fibers. Blockage may occur if the fabric vent is not well dried after washing and / or if the fabric vent is subjected to high humidity in cold weather. Once blockage occurs, it may take a long time for the fabric vent to recover and return to the initial ventilation flow. If a fabric vent is used under these conditions, high CO2 accumulation in the patient interface may result because the CO2 is not adequately vented. For the reasons stated above, fabric vents are not widely used in CPAP therapy.
[0281] One aspect of the present technology relates to a fabric vent assembly that is constructed and arranged to address water retention issues and allow adequate ventilation flow when the fabric becomes clogged due to being wetted by water or moisture. Thus, a fabric vent assembly according to one aspect of the present technology allows the use of fabric as a safe and reliable ventilation component for CPAP therapy.
[0282] In the illustrated example, the vent assembly 4400 is in the form of a vent insert or cartridge configured to be inserted into an opening in the patient interface 3000 or an air delivery conduit (eg, the air circuit 4170).
[0283] For example, Figures 4A to 4D A vent assembly 4400 is shown configured to be inserted into an opening 6050 of an air delivery conduit 6000. In use, the vent assembly 4400 is constructed and arranged to allow gas to flow from the interior or pressurized volume of the air delivery conduit 6000 to the exterior of the air delivery conduit 6000, such as to the atmosphere. The vent assembly 4400 can be removably or permanently fixed within the opening 6050 in any suitable manner, such as a press-fit assembly, a snap or interference fit assembly (for example, the vent assembly may include a groove around its periphery, the groove being suitable for positioning the vent assembly against a correspondingly sized edge of the opening of the air delivery conduit), an adhesive. In an alternative example, one or more portions of the vent assembly 4400 can be formed as one piece with the air delivery conduit 6000, such as by overmolding or insert molding.
[0284] In an optional example, ventilation assembly 4400 can be provided to patient interface 3000, e.g., plenum chamber 3200 or connection port 3600, to allow gas to flow from the interior of the patient interface (e.g., plenum chamber) to the exterior of the patient interface (e.g., to the atmosphere).
[0285] like Figures 4E to 4H As shown, the vent assembly 4400 includes a base 4700, a layer of fabric material 4600 supported by the base 4700, a cover 4500 that holds the fabric material 4600 within the base 4700, and a membrane 4800 constructed and arranged to regulate the vent flow through the vent assembly 4400 to provide adequate flushing of gas during use.
[0286] The base 4700 includes a base wall 4705 having at least one first orifice 4710 extending through the base wall 4705 to allow gas to be exhausted to the surrounding environment or atmosphere and at least one second orifice 4720 allowing gas to be exhausted to the atmosphere. The base wall 4705 includes an inner surface 4730 adapted to be oriented toward the interior (i.e., the pressurizable volume) of the air delivery conduit 6000 in use and an outer surface 4740 adapted to be oriented toward the atmosphere in use. A flange or shoulder 4750 is provided along the periphery of the base wall 4705 to align and support the fabric material 4600 on the outer surface 4740 of the base 4700. A retaining structure 4760 is provided on the inner surface 4730 of the base 4700 to retain the membrane 4800 adjacent to the inner surface 4730.
[0287] In one example, the base 4700 can be constructed (e.g., molded) from a relatively rigid material, such as a thermoplastic polymer (e.g., polycarbonate). In one example, the base 4700 can include a thickness of about 1-3 mm, such as about 2 mm, although other suitable thicknesses are possible.
[0288] In the illustrated example, the fabric material 4600 includes at least one aperture 4610 extending through the fabric material 4600. The fabric material 4600 is configured to be supported on the outer surface 4740 of the base 4700, held within a flange or shoulder 4750 provided along the periphery of the base 4700. As shown, the fabric material 4600 is arranged to cover the first aperture 4710 of the base 4700, so that the flow exiting the first aperture 4710 flows into the fabric material 4600. In addition, the aperture 4610 of the fabric material 4600 is arranged to align with the second aperture 4720 of the base 4700, so that the second aperture 4720 is not covered by the fabric material 4600 and the flow exiting the second aperture 4720 will not flow into the fabric material 4600.
[0289] In one example, the fabric material 4600 can be constructed of a porous material that allows gas to flow through the material but diffuses away from any jet or other flow formation of the first orifice 4710, such as a non-woven fiber material, a woven fiber material. In one example, the fabric material 4600 can include a diffusion material that can be similar or the same as the filter medium. In one example, the fabric material 4600 can include a thickness of about 0.1-0.5 mm, such as about 0.25 mm, although other suitable thicknesses are possible. In the illustrated example, the fabric material 4600 includes a single layer, however it should be understood that the fabric material 4600 can include two or more layers similar or different from the diffusion material, such as a laminate.
[0290] The cover 4500 includes a main wall 4510 and side walls 4520 that form the periphery of the vent assembly 4400. The main wall 4510 includes a grill-like configuration (e.g., one or more crossbars) that forms a slot or exit aperture 4530 through the cover 4500. The grill-like configuration allows flow therethrough while retaining the fabric material 4600 within the base 4700 and minimizing contact, e.g., to prevent contamination.
[0291] The cover 4500 is engaged with the base 4700 until the major wall 4510 abuts the flange or shoulder 4750 along the perimeter of the base 4700. The flange or shoulder 4750 supports the cover 4500 and its major wall 4510 in a spaced relationship from the outer surface 4740 of the base 4700 to contain and retain the fabric material 4600 between the cover 4500 and the base 4700, that is, the cover 4500 and the base 4700 form a housing or cylinder for the fabric material 4600. The sidewall 4520 of the cover 4500 extends downwardly along the outer perimeter of the base 4700. The cover 4500 can be removably or permanently secured to the base 4700 in any suitable manner (e.g., a press-fit assembly, a snap or interference fit assembly, an adhesive, etc.). In the example shown, the side wall 4520 also forms an interface with the opening 6050 in the air delivery conduit 6000, such as a press fit assembly, a snap or interference fit assembly, an adhesive.
[0292] In one example, the cover 4500 can be removably secured to the base, for example, to allow cleaning and / or replacement of the fabric material 4600. Alternatively, the entire vent assembly 4400 can be replaced, rather than replacing the fabric material 4600 alone.
[0293] In an alternative example, the vent assembly 4400 can be provided without the cover 4500, and the fabric material 4600 can be secured to the base 4700 in other suitable ways (e.g., adhered or overmolded to the fabric material on the base). In an example, the fabric material 4600 can be more exposed to facilitate drying. Moreover, this arrangement eliminates components used to reduce the overall size of the vent assembly, such as height, such as a lower profile.
[0294] In one example, cover 4500 can be constructed (e.g., molded) from a relatively rigid material, such as a thermoplastic polymer (e.g., polycarbonate). In one example, cover 4500 can include a height of about 2-5 mm, such as about 3.5 mm, although other suitable heights are possible.
[0295] The membrane 4800 includes a flap portion 4810 that is movably connected (e.g., hingedly connected via a hinge portion) to a retaining portion 4820 that allows the flap portion 4810 to pivot relative to the retaining portion 4820. The retaining portion 4820 is constructed and arranged to engage within a slot 4765 provided to the retaining structure 4760 of the base 4700 to secure the membrane 4800 to the base 4700. The retaining portion 4820 can be removably or permanently secured to the retaining structure 4760 of the base in any suitable manner (e.g., a press-fit assembly, a snap or interference fit assembly, an adhesive, etc.).
[0296] The flap portion 4810 of the membrane 4800 includes an orifice 4815 extending through the flap portion 4810. The membrane 4800 is supported by a retaining structure 4760 adjacent to the inner surface 4730 of the base 4700. The flap portion 4810 is freely movable toward and away from the inner surface 4730 of the base, for example, depending on the presence of pressurized gas and / or the obstruction of the fabric material 4600. The orifice 4815 of the flap portion 4810 is arranged to align with the first orifice 4710 of the base 4710, so that the first orifice 4710 cannot be completely covered or closed by the membrane 4800 to allow flow through the first orifice 4710. In addition, the flap portion 4810 is arranged to overlap with the second orifice 4720 of the base 4710, so that the second orifice 4720 can be selectively covered or closed by the membrane 4800 to restrict flow through the second orifice 4720.
[0297] In one example, the membrane 4800 can be comprised of a relatively flexible elastic material such as silicone or other thermoplastic elastomer. In one example, the membrane 4800 can include a thickness of about 0.25-0.75 mm, such as about 0.45 mm, although other suitable thicknesses are possible.
[0298] The assembled vent assembly 4400 provides a low profile configuration that does not significantly protrude into the interior of the air delivery conduit 6000. In one example, the vent assembly 4400 can include a height of about 2-5 mm, such as about 3.5 mm, a width of about 5-15 mm, such as 10 mm, and a length of about 10-30 mm, such as 20 mm, although other suitable dimensions are possible.
[0299] In the illustrated example, the vent assembly 4400 and the corresponding opening 6050 in the air delivery conduit 6000 comprise a stadium shape, i.e., a rectangle with semicircular shapes on opposite sides. However, it should be understood that the corresponding openings in the vent assembly and the air delivery conduit may have other suitable shapes, such as circular and non-circular.
[0300] The vent assembly 4400 is constructed and arranged to provide (1) a primary ventilation flow path V1 that passes through the fabric material 4600 to diffuse the exhaust ventilation flow to produce less noise, and (2) an auxiliary ventilation flow path V2 that bypasses the fabric material 4600 to allow adequate gas flushing when the fabric material 4600 is blocked due to water or moisture. The membrane 4800 is constructed and arranged to regulate the ventilation flow along the primary and auxiliary ventilation flow paths V1, V2.
[0301] As follows, ventilation assembly 4400 is constructed and arranged to allow adequate ventilation flow in various situations during respiratory therapy, for example, when there is no air pressure or low pressure in air delivery conduit 6000, when there is air pressure in air delivery conduit 6000, and when there is air pressure in air delivery conduit 6000 but fabric material 4600 is blocked. Ventilation assembly 4400 is constructed and arranged to operate under adverse conditions and allows the use of fabric material or similar porous materials as a safe and reliable vent component for respiratory therapy. In one example, ventilation flow can be continuous during respiratory therapy.
[0302] like Fig. 4I As shown, when there is no air pressure or low pressure in the air delivery conduit 6000 (e.g., when the RPT device is not operating or the air delivery conduit is blocked during use) and the fabric material 4600 is not blocked, the membrane 4800 takes a static or unactivated position so that air can pass through both the primary ventilation flow path and the auxiliary ventilation flow paths V1, V2. That is, pressurized gas is not delivered to the air delivery conduit 6000 or does not have sufficient strength to allow the membrane 4800 to drop or deflect downwardly away from the inner surface 4730 of the base 4700 and the first and second orifices 4710, 4720. As a result, air can pass through the primary ventilation flow path V1, which extends through the first orifice 4710, through the fabric material 4600, and through the cover 4500. In addition, air can pass through the auxiliary ventilation flow path V2, which extends through the second aperture 4720, through the aperture 4610 of the fabric material 4600, and through the cover 4500. When the membrane 4800 is in a resting or unactivated position, a majority of the fabric material 4600 is exposed through the first aperture 4710, which provides a low impedance air path for the patient to breathe in ambient air and exhale through the primary ventilation flow path V1. The auxiliary ventilation flow path V2 also provides a low impedance air path for the patient to breathe and exhale in ambient air.
[0303] like Figure 4JAs shown, when there is air pressure in the air delivery conduit 6000 (e.g., when the RPT device is operating) and the fabric material 4600 is not blocked, the increase in pressure within the pressurized volume of the air delivery conduit 6000 pushes or moves the membrane 4800 into the activated position so that air can only pass through the primary ventilation flow path V1. That is, the air pressure in the air delivery conduit 6000 is of sufficient magnitude to force and maintain the membrane 4800 in engagement with the inner surface 4730 of the base 4700. As a result, the aperture 4815 of the wing portion 4810 is arranged to align with the first aperture 4710 of the base 4700 so that air can pass through the primary ventilation flow path V1, which will extend through the aperture 4815 of the wing portion 4810, through the first aperture 4710 of the base 4700, through the fabric material 4600, and through the cover 4500. Furthermore, the flap portion 4810 is arranged to cover or close the second aperture 4720 of the base 4710 so that air flow through the auxiliary ventilation flow path V2 is restricted or blocked by the membrane 4800. When the membrane 4800 is in the activated position, air flow is restricted to the primary ventilation flow path V1 which directs all flow through the fabric material layer 4600 to the atmosphere to diffuse the exhaust ventilation flow to produce less noise.
[0304] In addition, the size of the orifice 4815 of the fin portion 4810 is adapted to regulate the flow along the main ventilation flow path V1. That is, the orifice 4815 of the fin portion 4810 forms an inlet for the exhaust flow along the main ventilation flow path V1, and the size of the orifice 4815 (e.g., the cross-sectional area of the orifice 4815) can be adjusted to provide a desired flow curve within a therapeutic pressure range, for example, a substantially constant flow rate over a therapeutic pressure range between 4-20 cmH2O.
[0305] like Figure 4K As shown, when there is air pressure in the air delivery conduit 6000 (e.g., when the RPT device is operating) and the fabric material 4600 is blocked due to water or moisture, the membrane 4800 will not be fully activated, so that air can pass through the auxiliary ventilation flow path V2 while the main ventilation flow path V1 is blocked. That is, the membrane 4800 and the base 4700 are configured and arranged so that the blockage of the fabric material 4600 changes the flow and force applied to the membrane 4800, which allows the membrane 4800 to move away from the inner surface 4730 of the base 4700 and the first orifice 4710 and the second orifice 4720. As a result, air can pass through the auxiliary ventilation flow path V2, which extends through the second orifice 4720, through the orifice 4610 of the fabric material 4600, and through the cover 4500. This allows air flow to be restricted to the auxiliary ventilation flow path V2, which bypasses the fabric material 4600 to provide sufficient ventilation flow while the fabric material 4600 is blocked.
[0306] The size of the second orifice 4720 of the base 4700 is suitable for regulating the flow along the auxiliary ventilation flow path V2. That is, the second orifice 4720 of the base 4700 forms an inlet for the exhaust flow along the auxiliary ventilation flow path V2, and the size of the second orifice 4720 (e.g., the cross-sectional area of the orifice 4720) can be adjusted to provide a desired flow curve within the treatment pressure range, for example, a substantially constant flow rate over the treatment pressure range between 4-20 cmH2O. For example, the second orifice 4720 is adjusted to provide sufficient air flow, i.e., a low impedance air path, to prevent CO2 from accumulating in the patient interface.
[0307] Furthermore, the auxiliary ventilation flow path V2 will remain open until the fabric material 4600 along the primary ventilation flow path V1 is sufficiently dry or unobstructed to allow adequate exhaust ventilation flow.
[0308] In one example, the membrane 4800 can be constructed and arranged to react to the impedance of air flow through the fabric material 4600, i.e., to the degree of moisture or dryness of the fabric material 4600. For example, when the fabric material 4600 is dry, the membrane can gradually move toward the activation position, such that as the drying of the fabric material 4600 allows the air flow through the main ventilation flow path V1 to gradually increase, the air flow through the auxiliary ventilation flow path V2 is gradually reduced. In another example, when the fabric material 4600 becomes more moist (e.g., due to moisture), the membrane can gradually move away from the activation position, such that as the humidity of the fabric material 4600 causes the air flow through the main ventilation flow path V1 to gradually decrease, the air flow through the auxiliary ventilation flow path V2 is gradually increased. Thus, the membrane can be constructed and arranged to gradually deflect toward and away from the activation position due to the drying of the fabric material to divide or distribute the ventilation flow between the main ventilation flow path V1 and the auxiliary ventilation flow path V2 throughout the treatment pressure.
[0309] As above, aspects of ventilation assembly 4400 can be adjusted to provide a desired flow curve within a therapeutic pressure range. In one example, the ventilation characteristics of each ventilation component can be adjusted, for example, based on ventilation needs, sound needs, treatment needs, etc. This arrangement allows for a more customized ventilation assembly for the patient.
[0310] For example, for membrane 4800, the thickness, length, material, and shape of the membrane can be adjusted to deform in a desired manner, and the shape, size, and number of orifices 4815 through membrane 4800 can be adjusted to adjust the flow rate. With respect to base 4700, the shape, size, and number of at least one first orifice 4710 and the shape, size, and number of at least one second orifice 4720 can be adjusted to adjust the flow rate. With respect to fabric 4600, the thickness and material of fabric 4600 can be adjusted to adjust the flow rate. With respect to cover 4500, the shape, size, and number of orifices 4530 through cover 4500 can be adjusted to adjust the flow rate.
[0311] Figures 5A to 5G A fabric vent assembly 4400 according to another example of the present technology is shown. In the example, the vent assembly 4400 also includes an activator 4900, which is constructed and arranged to deflect the membrane 4800 away from the activated position when the fabric material 4600 is exposed to water, that is, when the fabric material is wet, so that the ventilation flow through it is significantly reduced.
[0312] Similar to the above example, Figures 5A to 5G The vent assembly 4400 in the embodiment includes a base 4700, a layer of fabric material 4600 supported by the base 4700, a cover 4500 that holds the fabric material 4600 within the base 4700, and a membrane 4800 that is constructed and arranged to regulate the ventilation flow through the vent assembly 4400 to provide adequate flushing of gas during use. In addition, Figures 5A to 5G The vent assembly 4400 in FIG. 4 includes an activator 4900 disposed within a recess 4770 disposed on an inner surface 4730 of a base 4700 to hold the activator 4900 proximate to a membrane 4800 .
[0313] In one example, the activator 4900 includes a swellable polymer material (e.g., a polymer) configured to rapidly swell when exposed to water, and this swelling is used to engage and deflect the membrane 4800. The higher the swelling percentage of the material, the less thickness of the material is required to deflect the membrane 4800. It should be understood that any material that can undergo a process known as osmosis and rapidly swell when exposed to water can be used as an activator. In an alternative example, natural fibers can be used as an activator.
[0314] Similar to the above example, Figure 5E As shown, when there is no air pressure or low pressure in the air delivery conduit 6000 (for example, when the RPT device is not operating or the air delivery conduit is blocked during use) and the fabric material 4600 is not blocked, the membrane 4800 assumes a static or unactivated position so that air can pass through both the main ventilation flow path and the auxiliary ventilation flow paths V1, V2.
[0315] like Fig. 5F As shown, when there is air pressure in the air delivery conduit 6000 (e.g., when the RPT device is operating) and the fabric material 4600 is not blocked, the pressure increase within the pressurized volume of the air delivery conduit 6000 pushes or moves the membrane 4800 into the activated position so that air can only pass through the main ventilation flow path V1. When the fabric material 4600 and the activator 4900 are dry, the activator 4900 shrinks or is in a non-expanded configuration so that the activator 4900 remains immersed or recessed in the recess 4770 and does not affect any deflection of the membrane 4800 from the activated position. Therefore, the fin portion 4810 is arranged to cover or close the second aperture 4720 so that the air flow is restricted to the main ventilation flow path V1, which directs all flow through the fabric material 4600 layer to diffuse the exhaust ventilation flow, thereby generating less noise.
[0316] like Figure 5G As shown in , when there is air pressure in the air delivery conduit 6000 (e.g., when the RPT device is operating) but the fabric material 4600 is blocked due to water or moisture, such water or humidity causes the activator to expand into an expanded configuration, so that the activator 4900 extends out of the recess 4770 to engage and force the diaphragm 4800 away from the inner surface 4730 of the base 4700 and the first orifice 4710 and the second orifice 4720. That is, when exposed to water to deflect the membrane 4800, the activator 4900 becomes active so that air can pass through the auxiliary ventilation flow path V2 while the main ventilation flow path V1 is blocked. This allows air flow to be restricted to the auxiliary ventilation flow path V2, which bypasses the fabric material 4600 to provide sufficient ventilation flow while the fabric material 4600 is blocked.
[0317] In addition, the auxiliary ventilation flow path V2 will remain open until the fabric material 4600 along the primary ventilation flow path V1 is sufficiently dry or unobstructed to allow sufficient exhaust ventilation flow. For example, the activator 4900 will dry with the fabric material 4600 so that the activator 4900 will remain activated until the fabric material 4600 is sufficiently dry or unobstructed.
[0318] In one example, the membrane 4800 can be constructed and arranged to gradually deflect toward and away from the activation position due to the drying of the activator 4900 and, therefore, the drying of the fabric material 4600 to divide or distribute the ventilation flow between the primary ventilation flow path V1 and the auxiliary ventilation flow path V2 throughout the treatment pressure. For example, when the activator 4900 becomes more moist (e.g., due to water or moisture), the activator 4900 can gradually expand to gradually move the membrane 4800 away from the activation position, such that as the moisture of the fabric material 4600 causes the air flow through the primary ventilation flow path V1 to gradually decrease, the air flow through the auxiliary ventilation flow path V2 to gradually increase. Similarly, when the activator 4900 dries, the activator 4900 can gradually contract to allow the membrane 4800 to gradually move toward the activation position, such that as the drying of the fabric material 4600 allows the air flow through the primary ventilation flow path V1 to gradually increase, the air flow through the auxiliary ventilation flow path V2 to gradually decrease.
[0319] Figures 6A to 6K A fabric vent assembly 5400 including an activator 5900 is shown according to another example of the present technology. In this example, the vent assembly 5400 is provided without a cover, which enhances exposure of the fabric material 5600, for example, to facilitate drying. Moreover, this arrangement eliminates components used to reduce the overall size of the vent assembly, such as height, such as a lower profile.
[0320] Similar to the above examples, the ventilation assembly 5400 is in the form of a ventilation insert or box that is configured to be inserted into an opening in a patient interface or air delivery conduit, for example, removably or permanently secured within the opening 6050 of the air delivery conduit 6000, such as Figures 6A to 6D In an alternative example, one or more portions of the vent assembly 5400 can be formed as one piece with the air delivery conduit 6000, such as by overmolding or insert molding.
[0321] like Figures 6E to 6H As shown, the vent assembly 5400 includes a base 5700, a layer of fabric material 5600 supported by the base 5700, a membrane 5800 constructed and arranged to regulate the flow of vent air through the vent assembly 5400 to provide adequate flushing of gas in use, and an activator 5900 to deflect the membrane 5800.
[0322] The base 5700 includes a base wall 5705 having at least one first orifice 5710 extending through the base wall 5705 to allow gas to be exhausted to the atmosphere. The base wall 5705 also includes a plurality of second orifices 5720 to allow gas to be exhausted to the atmosphere. The base wall 5705 includes an inner surface 5730 adapted to be oriented toward the interior (i.e., the pressurizable volume) of the air delivery conduit 6000 in use and an outer surface 5740 adapted to be oriented toward the atmosphere in use. In the illustrated example, the plurality of second orifices 5720 extend from a circular protrusion 5742 along the outer surface 5740 to an inclined or ramped protrusion 5732 along the inner surface 5730. A retaining structure 5760 is provided on the inner surface 5730 of the base 5700 to retain the membrane 5800 near the inner surface 5730. Additionally, openings 5770 are provided on the base 5700 to hold the activator 5900 adjacent to the membrane 5800. In the illustrated example, the perimeter of the base 5700 forms an interface with the opening 6050 in the air delivery conduit 6000, such as a press fit assembly, a snap or interference fit assembly, an adhesive.
[0323] Similar to the above example, it should be understood that the shape, size and number of the second orifices 5720 can be adjusted to regulate flow.
[0324] In the illustrated example, the fabric material 5600 includes at least one aperture 5610 extending through the fabric material 5600. The fabric material 5600 is configured to be supported and retained on the outer surface 5740 of the base 5700. The fabric material 5600 can be fixed to the base 5700 in any suitable manner, for example, the fabric material is adhered or overmolded to the base. As shown, the fabric material 5600 is arranged to cover the first aperture 5710 of the base 5700, and the aperture 5610 of the fabric material 5600 is arranged to align with the circular protrusion 5742 along the outer surface 5740, so that the plurality of second apertures 5720 are not covered by the fabric material 5600.
[0325] The membrane 5800 includes a flap portion 5810 that is movably connected (e.g., hingedly connected via a hinge portion) to a retaining portion 5820 that allows the flap portion 5810 to pivot relative to the retaining portion 5820. In the illustrated example, the retaining portion 5820 includes an aperture 5822 and the retaining structure 5760 includes a post 5762 that is constructed and arranged to engage with the aperture 5822 to secure the membrane 5800 to the base 5700. However, the retaining portion 5820 may be removably or permanently secured to the retaining structure 5760 of the base in any suitable manner (e.g., a press-fit assembly, a snap or interference fit assembly, an adhesive, etc.).
[0326] The membrane 5800 is supported by a retaining structure 5760 adjacent to the inner surface 5730 of the base 5700. In the example shown, the flap portion 5810 includes a sufficient length to overlap the plurality of second apertures 5720 so that the second apertures 5720 can be selectively covered or closed by the membrane 5800 in use.
[0327] Activator 5900 is disposed within opening 5770 of base 5700 to hold activator 5900 proximate membrane 5800. Similar to the above examples, activator 5900 may include a swellable polymer material (eg, a polymer) or other suitable material that rapidly swells when exposed to water.
[0328] In the illustrated example, the vent assembly 5400 and the corresponding openings 6050 in the air delivery conduit 6000 comprise a stadium shape, however, it will be appreciated that the vent assembly and the corresponding openings in the air delivery conduit may have other suitable shapes, such as circular and non-circular.
[0329] Similar to the above example, Fig.6I As shown, when there is no air pressure or low pressure in the air delivery conduit 6000 (for example, when the RPT device is not operating or the air delivery conduit is blocked during use) and the fabric material 5600 is not blocked, the membrane 5800 assumes a static or unactivated position so that air can pass through both the main ventilation flow path and the auxiliary ventilation flow paths V1, V2.
[0330] like Figure 6J As shown, when there is air pressure in the air delivery conduit 6000 (e.g., when the RPT device is operating) and the fabric material 5600 is not blocked, the pressure increase within the pressurized volume of the air delivery conduit 6000 pushes or moves the membrane 5800 into the activated position so that air can only pass through the main ventilation flow path V1. When the fabric material 5600 and the activator 5900 are dry, the activator 5900 shrinks or is in a non-expanded configuration so that the activator 5900 remains immersed or recessed within the opening 5770 and does not affect any deflection of the membrane 5800 from the activated position. Therefore, the flap portion 5810 is arranged to cover or close the plurality of second apertures 5720 so that the air flow is restricted to the main ventilation flow path V1, which directs all flow through the fabric material 5600 layer to diffuse the ventilation exhaust flow to produce less noise.
[0331] like Figure 6KAs shown in , when there is air pressure in the air delivery conduit 6000 (e.g., when the RPT device is operating) but the fabric material 5600 is blocked due to water or moisture, such water or moisture causes the activator to expand into an expanded configuration, so that the activator 5900 extends out of the opening 5770 to engage and force the diaphragm 5800 away from the inner surface 5730 of the base 5700 and the first orifice 5710 and the plurality of second orifices 5720. That is, when exposed to water to deflect the membrane 4500, the activator 5900 becomes active so that air can pass through the auxiliary ventilation flow path V2 while the main ventilation flow path V1 is blocked. This allows air flow to be restricted to the auxiliary ventilation flow path V2, which bypasses the fabric material 5600 to provide sufficient ventilation flow while the fabric material 5600 is blocked.
[0332] Similar to the above example, the auxiliary ventilation flow path V2 will remain open until the fabric material 5600 along the primary ventilation flow path V1 is sufficiently dry or unobstructed to allow sufficient exhaust ventilation flow. In addition, the membrane 5800 is arranged to gradually deflect toward and away from the activation position due to the drying of the activator 5900 and therefore the drying of the fabric material 5600 to divide or distribute the ventilation flow between the primary ventilation flow path V1 and the auxiliary ventilation flow path V2 throughout the treatment pressure.
[0333] It should be understood that the auxiliary ventilation flow path V2 can be activated in other ways. For example, Figures 7A to 7C An alternative example of a vent assembly 5400 is shown that includes an electromagnetic activator 6900 constructed and arranged to deflect the membrane 5800.
[0334] In an example, the activator 6900 includes a sensor 6910 disposed along the inner surface 5730 of the base 5700. As shown, the sensor 6910 includes a circuit track 6915 configured and arranged to detect water, such as water between the circuit tracks, such as Figure 7C As shown. When water is detected, the sensor 6910 activates an electronic switch or control signal, which activates the activator 6900, for example, the activator 6900 includes a moving member (e.g., a plunger arrangement) that is constructed and arranged to engage and force the diaphragm 5800 away from the inner surface 5730 of the base 5700 and the first orifice 5710 and the plurality of second orifices 5720. The switch can be set to activate when a certain level of water / moisture is present on the vent assembly. In addition, the switch can be set to remain activated for a predetermined period of time, for example to ensure drying of the fabric material 5600 before deactivation. In one example, such a vent configuration with an electromagnetic activator 6900 can be used as an active vent, for example, to control the vent flow characteristics by controlling the flow through the primary and auxiliary vent flow paths V1, V2.
[0335] In an alternative example, the ventilation assembly may simply include a sensor that is configured and arranged to detect water / moisture on the ventilation assembly and then provide a signal to the RPT device so that the RPT device can alert the patient that the vent is wet and / or update operation accordingly, such as updating the delivery pressure to ensure safe use of the patient interface during the period of time when the vent is wet.
[0336] Fig. 8A and 8E A vent assembly 7400 according to an alternative example of the present technology is shown. In the example, the vent assembly 7400 includes a vent component 7900, which includes an expandable polymer material (e.g., a polymer) configured to expand rapidly when exposed to water, and this expansion is used to open the vent orifice 7925 through the vent component 7900 to activate the auxiliary ventilation flow path V2.
[0337] like Figures 8A to 8C As shown, the vent assembly 7400 includes a base 7700, a layer of fabric material 7600 supported by the base 7700, and a vent component 7900, which is constructed and arranged to regulate ventilation flow through the auxiliary ventilation flow path V2 to provide adequate flushing of gas in use.
[0338] The base 7700 includes a base wall 7705 having at least one first aperture 7710 extending therethrough to allow gas to vent to the atmosphere and a second aperture 7720 configured to support the vent component 7900 .
[0339] In the example shown, the fabric material 7600 is arranged to cover the first aperture 7710 of the base 7700, and the fabric material 7600 includes the aperture 7610 to align with the second aperture 7720 such that the second aperture 7720 is not covered by the fabric material 7600. In an example, the vent assembly 7400 is provided without a cover, and the fabric material 7600 can be secured to the base 7700 in any suitable manner, for example, the fabric material is adhered or overmolded to the base.
[0340] In one example, the polymer vent member 7900 is in the form of a grommet configured to be inserted into the second aperture 7720 of the base 7700. For example, the vent member 7900 may include a groove 7950 around its periphery, the groove 7950 being adapted to position the vent member 7900 against an edge or rim of the second aperture 7720 of the base 7700. The vent member 7900 and the base 7700 are arranged to provide sufficient clearance to allow the vent member 7900 to expand relative to the base 7700. However, the vent assembly 7400 may be removably or permanently secured within the base in other suitable manners.
[0341] In addition, the polymeric vent component 7900 includes a plurality of vent apertures 7925 that are constructed and arranged to regulate gas flow from the interior of the air delivery conduit 6000 to the exterior of the air delivery conduit 6000, for example, to the atmosphere. Specifically, the polymeric vent component 7900 is configured to expand and contract due to the presence of water / moisture, and such expansion / contraction effects expansion and contraction of the vent apertures 7925 to regulate flow along the auxiliary ventilation flow path V2.
[0342] It should be understood that the shape, size and number of the second orifices 7925 can be adjusted to regulate the flow rate.
[0343] like Fig.8D As shown, when the fabric material 7600 and polymer component 7900 are dry, the apertures 7925 of the polymer component 7900 are substantially closed or contracted such that little or no flow can flow through the apertures 7925. Thus, air flow is restricted to the primary ventilation flow path V1, which directs all flow through the fabric material layer 7600 to diffuse the exhaust ventilation flow to generate less noise.
[0344] like Fig. 8E As shown, when the fabric material 7600 is blocked due to water or moisture, such water or moisture causes the polymeric vent component 7900 to expand into an expanded configuration that opens or expands the apertures 7925 so that air can flow through the apertures 7925. This allows air to flow along the auxiliary ventilation flow path V2, which bypasses the fabric material 7600 to provide sufficient ventilation flow while the fabric material 7600 is blocked. The polymeric vent component 7900 will remain activated until the fabric material 7600 is sufficiently dry or unblocked.
[0345] In one example, the polymer vent component 7900 can be constructed and arranged to gradually expand and contract due to the wetness of the polymer vent component 7900 and thus the wetness of the fabric material 7600 to divide or distribute the ventilation flow between the main ventilation flow path V1 and the auxiliary ventilation flow path V2 throughout the treatment pressure. For example, when the polymer vent component 7900 becomes more wet (e.g., due to water or moisture), the polymer vent component 7900 can gradually expand to gradually open the orifice 7925, so that as the humidity of the fabric material 7600 causes the air flow through the main ventilation flow path V1 to gradually decrease, the air flow through the auxiliary ventilation flow path V2 gradually increases. Similarly, when the polymer vent component 7900 dries, the polymer vent component 7900 can gradually contract to allow the orifice 7925 to gradually close, so that as the fabric material 7600 dries, the air flow through the main ventilation flow path V1 is allowed to gradually increase, and the air flow through the auxiliary ventilation flow path V2 is gradually reduced.
[0346] Figures 9A to 9FA fabric vent assembly 8400 according to another example of the present technology is shown. In the example, the vent assembly 8400 includes a vent member 8500 (e.g., including a layer of fabric material 8510, the layer of fabric material 8510 having a plurality of vent holes 8530 extending therethrough) and a diffuser member 8600 (e.g., including a layer of fabric material 8610) along a vent flow path, the diffuser member 8600 being constructed and arranged to diffuse the exhaust vent flow to generate less noise. Since both the vent member 8500 and the diffuser member 8600 include fabric materials, the vent assembly 8400 can include a thinner, more compact and miniaturized configuration.
[0347] In one example, ventilation assembly 8400 can be in the form of a ventilation insert or ventilation module configured to be inserted into an opening in a patient interface or air delivery conduit (e.g., a frame or housing of a patient interface forming at least a portion of a plenum chamber).
[0348] The vent assembly 8400 can be removably or permanently secured within the opening in any suitable manner, such as a press-fit assembly, a snap-fit or interference-fit assembly (e.g., the vent assembly 8400 may include a groove around its periphery that is suitable for positioning the vent assembly 8400 against an edge of a corresponding size of the opening of the frame), or an adhesive.
[0349] In optional instances, one or more portions of ventilation assembly 8400 can include a portion of a patient interface or air delivery conduit (e.g., a frame of a patient interface), or can be formed as one piece with a patient interface or air delivery conduit (e.g., a frame of a patient interface) (e.g., by overmolding or insert molding).
[0350] In the illustrated example, the vent assembly 8400 (and the corresponding opening in the frame) comprises a stadium shape, i.e., a rectangle with semicircular shapes on opposite sides. However, it should be understood that the vent assembly (and the corresponding opening in the frame) can have other suitable shapes, such as circular and non-circular.
[0351] In use, ventilation assembly 8400 is constructed and arranged to allow gas to flow between a pressurized interior of a patient interface or air delivery conduit (e.g., a plenum chamber) and an exterior of the patient interface or air delivery conduit (e.g., atmosphere).
[0352] like Figures 9A to 9F As shown in the example, the ventilation assembly 8400 includes a base or frame 8700, a ventilation member 8500 supported by the base 8700 (e.g., including a layer of fabric material 8510 having a plurality of ventilation holes 8530 extending therethrough), a diffusion member 8600 (e.g., including a layer of fabric material 8610), and a support structure 8800 to support the diffusion member 8600 in an offset or spaced relationship with the ventilation member 8500.
[0353] The base 8700 includes an outer wall 8710 that forms an opening 8720 therethrough. As described above, the base 8700 can be removably or permanently secured in any suitable manner within an opening in a patient interface or air delivery conduit to secure the ventilation assembly 8400 to the patient interface or air delivery conduit. Alternatively, as described above, the base 8700 and its opening 8720 can comprise a portion of the patient interface or air delivery conduit, or be formed in one piece with the patient interface or air delivery conduit, such as by overmolding or insert molding.
[0354] The ventilation member 8500 is supported by the outer wall 8710 of the base 8700 along the front side of the base 8700. As shown, the ventilation member 8500 is arranged to cover the opening 8720 of the base 8700 so that the ventilation flow of the patient's exhaled gas can pass through the opening 8720 and through the plurality of ventilation holes 8530 in the ventilation member 8500.
[0355] In one example, the fabric material 8510 comprises a fabric material sheet having a thickness of about 0.10 mm to 0.30 mm, for example, 0.19 mm. However, it should be understood that other suitable thicknesses are also possible. In one example, each of the plurality of vents 8530 comprises a diameter of about 0.18 mm to 0.20 mm. In one example, the diameter of each of the plurality of vents 8530 is not less than about 0.18 mm (i.e., greater than about 0.18 mm), for example, to prevent potential water blockage. In one example, the plurality of vents 8530 can be laser cut through the fabric material 8510.
[0356] In one example, the fabric material 8510 can be attached to the base 8700, and then the vents 8530 can be laser cut through the fabric material 8510 while attached to the base 8700. In an alternative example, the vents 8530 can be laser cut through the fabric material 8510, and then the fabric material 8510 with the vents 8530 can be attached to the base 8700.
[0357] The support structure 8800 includes an outer wall 8810 forming an opening 8820 therethrough and a plurality of support members 8830 protruding from a rear side of the outer wall 8810. In the illustrated example, the support members 8830 are provided to the outer wall 8810 along the major and minor axes of the support structure 8800, however it should be understood that the support members 8830 may be arranged along the perimeter of the outer wall 8810 in other suitable manners.
[0358] The diffusion member 8600 is supported by an outer wall 8810 of the support structure 8800 along the front side of the support structure 8800. In the illustrated example, the diffusion member 8600 includes a layer of fabric material 8610 arranged to cover an opening 8820 of the support structure 8600. In addition, the diffusion member 8600 forms a cover or exterior of the ventilation assembly 8400. In one example, the fabric material of the diffusion member 8600 located on the exterior of the ventilation assembly 8400 facilitates cleaning of the ventilation assembly 8400. In addition, such a fabric exterior can provide aesthetic appeal, particularly when coupled with a fabric patient orifice or a fabric air delivery conduit.
[0359] The support structure 8800 and the diffusion member 8600 supported thereon are disposed on the front side of the base 8700 and the vent member 8500 supported thereon. As shown, the support member 8830 is arranged to engage along the perimeter of the vent member 8500 so that the vent member 8500 is sandwiched between the support member 8830 and the outer wall 8710 of the base 8700. In addition, the support member 8830 is arranged to support the outer wall 8810 and the diffusion member 8600 thereon in a spaced relationship from the front side of the base 8700 and the vent member 8500. This arrangement forms a lateral opening 8450 along the perimeter of the vent assembly so that at least a portion of the flow out of the vent hole 8530 can bypass the diffusion member 8600 and flow through the lateral opening 8450. Such an arrangement also offsets the diffusion member 8600 from the vent member 8500 by a gap 8475, which can resist any moisture or dirt that may block the diffusion member 8600 while allowing air to continue to flow. In one example, the gap 8475 can have a height of about 1-2 mm, such as 1.5 mm. However, it should be understood that the gap 8475 can have other suitable dimensions, which can vary with the ventilation flow rate and ventilation area.
[0360] In one example, the diffusion member 8600 can be constructed of a porous material that allows gas to flow through the material but diffuses out of any jet or other flow pattern of the plurality of vents 8530, such as a fabric material 8610, such as a non-woven fiber material or a woven fiber material. In one example, the diffusion member 8600 can include a fabric non-breaking ring (UBL) material having a thickness of about 0.10 mm to 0.30 mm, such as 0.20 mm. However, it should be understood that other suitable fabric materials and thicknesses are possible.
[0361] In one example, the base 8700 and support structure 8800 can include a relatively rigid or relatively soft construction. Because both the ventilation member 8500 and the diffusion member 8600 include a flexible fabric material, the base 8700 and support structure 8800 (together with the ventilation member 8500 and the diffusion member 8600) can bend to follow the contours of a patient interface or air delivery conduit, for example, the soft, flexible construction of the base 8700 and support structure 8800 can be bent or curved to follow the contour, or the base 8700 and support structure 8800 can have a rigid construction that is molded or otherwise formed to follow the contour.
[0362] like Fig.9E As shown, when there is pressure in the patient interface or air delivery conduit (e.g., when the RPT device is operating) and the diffusion member 8600 is not blocked, air can pass through the main ventilation flow path V1, which will extend through the plurality of ventilation holes 8530 and through the diffusion member 8600 to the atmosphere to diffuse the exhaust flow to produce less noise. In addition, air can pass through the auxiliary ventilation flow path V2 extending through the plurality of ventilation holes 8530 and through the lateral opening 8450 to the atmosphere. Such main and auxiliary ventilation flow paths V1, V2 provide ventilation paths to allow sufficient gas flushing to prevent CO2 from accumulating in the patient interface or air delivery conduit.
[0363] like Fig.9F As shown, when there is pressure in the patient interface or air delivery conduit (e.g., when the RPT device is operating) and the diffusion member 8600 is blocked due to water or moisture, air can pass through the auxiliary ventilation flow path V2 extending through the plurality of vent holes 8530 and through the lateral opening 8450 to the atmosphere. The auxiliary ventilation flow path V2 bypasses the diffusion member 8600 to provide sufficient ventilation flow when the diffusion member 8600 is blocked. In addition, the auxiliary ventilation flow path V2 is always open, which ensures sufficient exhaust ventilation flow until the diffusion member 8600 along the main ventilation flow path V1 is fully dried or opened.
[0364] Figures 10A to 10F A fabric vent assembly 9400 is shown in accordance with another example of the present technology. The vent assembly 9400 is similar to the vent assembly 8400 described above, but includes a different arrangement for supporting a vent member 9500 and a diffuser member 9600.
[0365] like Figures 10A to 10FAs shown in the example of , the vent assembly 9400 includes a frame 9700, a vent member 9500 (e.g., including a layer of fabric material 9510 having a plurality of vent holes 9530 extending therethrough) supported along a rear side of the frame 9700, and a diffuser member 9600 (e.g., including a layer of fabric material 9610) supported along a front side of the frame 9700. In the example, the frame 9700 supports the diffuser member 9600 in an offset or spaced relationship from the vent member 9500.
[0366] The frame 9700 includes a rear wall 9710 through which an opening 9720 is formed, a front wall 9740 through which an opening 9750 is formed, and a plurality of support members 9730 that separate and support the front wall 9740 from the rear wall 9710. In the illustrated example, the support members 9730 are disposed along the major and minor axes of the frame 9700, however it should be understood that the support members 9730 may be arranged along the perimeter of the frame 9700 in other suitable manners. In addition, the rear wall 9710, the front wall 9740, and the support members 9730 form lateral openings 9450 along the perimeter of the vent assembly so that at least a portion of the flow exiting the vent 9530 may bypass the diffuser member 9600 and flow through the lateral openings 9450.
[0367] The vent member 9500 is supported along the rear side of the frame 9700 by the rear wall 9710 of the frame 9700, and the diffuser member 9600 is supported along the front side of the frame 9700 by the front wall 9740 of the frame 9700. As such, the frame 9700 provides a support structure in which the diffuser member 9600 is supported in a spaced relationship from the vent member 9500, which forms a gap 9475 to resist any moisture or dirt that may clog the diffuser member 9600 as described above.
[0368] Similar to the ventilation assembly 8400 described above, the frame 9700 may include a relatively rigid or relatively soft structure. Because both the ventilation member 9500 and the diffuser member 9600 include a flexible fabric material, the frame 9700 (together with the ventilation member 9500 and the diffuser member 9600) may bend to follow the contours of a patient interface or air delivery conduit, e.g., a soft, flexible construction of the frame 9700 may be bent or curved to follow the contours, or the frame 9700 may have a rigid construction that is molded or otherwise formed to follow the contours.
[0369] like Fig. 10EAs shown, when there is pressure in the patient interface or air delivery conduit (e.g., when the RPT device is operating) and the diffusion member 9600 is not blocked, air can pass through the main ventilation flow path V1, which will extend through the plurality of ventilation holes 9530 and through the diffusion member 9600 to the atmosphere to diffuse the exhaust flow to produce less noise. In addition, air can pass through the auxiliary ventilation flow path V2 extending through the plurality of ventilation holes 9530 and through the lateral opening 9450 to the atmosphere. Such main and auxiliary ventilation flow paths V1, V2 provide ventilation paths to allow sufficient gas flushing to prevent CO2 from accumulating in the patient interface or air delivery conduit.
[0370] like Fig.10F As shown, when there is pressure in the patient interface or air delivery conduit (e.g., when the RPT device is operating) and the diffusion member 9600 is blocked due to water or moisture, air can pass through the auxiliary ventilation flow path V2 extending through the plurality of vent holes 9530 and through the lateral openings 9450 to the atmosphere. The auxiliary ventilation flow path V2 bypasses the diffusion member 9600 to provide sufficient ventilation flow when the diffusion member 9600 is blocked. In addition, the auxiliary ventilation flow path V2 is always open, which ensures sufficient exhaust ventilation flow until the diffusion member 9600 along the main ventilation flow path V1 is fully dried or opened.
[0371] In each of the above examples, the total ventilation flow through the ventilation assembly can ideally include the sum of the main ventilation flow through the main ventilation flow path V1, the auxiliary ventilation flow through the auxiliary ventilation flow path V2, and any leakage in the ventilation assembly (e.g., about 0.1-0.2 L / min). Therefore, for a given pressure, a reduction in the main ventilation flow should be compensated by an increase in the auxiliary ventilation flow. In one example, the change in the ventilation flow rate in the main and auxiliary ventilation flow paths can depend on how quickly moisture accumulates in the ventilation assembly and how quickly the moisture dries. The span of ventilation flow between the main ventilation flow path and the auxiliary ventilation flow path can depend on the design and can be adjusted as described above.
[0372] Figures 11A to 11F is a chart showing some exemplary ventilation flow possibilities.
[0373] exist Fig.11A In an example, the ventilation assembly can be configured such that throughout the entire treatment pressure range, the auxiliary ventilation flow gradually increases as the main ventilation flow gradually decreases.
[0374] exist Fig. 11BIn an example of this, the ventilation assembly can be configured such that the auxiliary ventilation device remains closed until a certain therapeutic pressure is reached (e.g., 8 cmH2O), after which the auxiliary ventilation flow is gradually increased as the main ventilation flow continues to gradually decrease.
[0375] exist Fig. 11C In an example, the ventilation assembly can be configured such that the auxiliary ventilation flow is gradually increased as the primary ventilation flow is gradually reduced until a certain therapeutic pressure (e.g., 10 cmH2O) is reached, which is large enough to clear the blockage in the primary ventilation port, and thereafter the auxiliary ventilation flow is gradually reduced as the primary ventilation flow is gradually increased.
[0376] exist Fig.11D In an example, the vent assembly can be configured such that the auxiliary vent is activated once the primary vent becomes wet (e.g., due to water or moisture). In an example, if the primary vent is wet, the primary vent flow is reduced by about 50% of its original or dry flow, and after the vent assembly is exposed to moisture, the auxiliary vent is activated to increase the total vent flow. This increase provided by the auxiliary vent can be adjusted to ensure adequate gas flushing during use.
[0377] exist Fig.11E In an example of , the vent assembly can be configured such that when the primary vent becomes wet (e.g., due to water or moisture), the auxiliary vent remains closed until a certain level of water saturation or a certain level of obstruction in the primary vent is reached, after which the auxiliary vent activates to increase total vent flow. Fig.11D Similar to the example of, if the primary vent is wet, the primary ventilation flow is reduced by about 50% of its original or dry flow. In the example, the auxiliary vent is activated at about 8 cmH2O, however it should be understood that activation can occur at lower or higher pressures, for example depending on the level of water saturation or obstruction as described above. In addition, in one example, the auxiliary vent can be electronically activated via an electromechanical system, for example see electromagnetic activator 6900 described above. The increase in total ventilation flow provided by the auxiliary vent can be adjusted to ensure adequate gas flushing during use.
[0378] exist Fig.11FIn an example, the ventilation assembly can be configured so that the auxiliary vent is activated once the main vent becomes wet (e.g., due to water or moisture). In an example, at low pressure (e.g., less than about 10 cmH2O, e.g., 4-10 cmH2O), the main ventilation flow is reduced by about 50% of its original or dry flow because it is wet, and the auxiliary vent is activated to increase the total ventilation flow. At a higher pressure (e.g., greater than about 10 cmH2O, e.g., 10-20 cmH2O), the pressure in the vent is sufficient to clear the water or obstruction in the main vent, after which the main ventilation flow can be increased, and the auxiliary ventilation flow can be gradually reduced or maintained substantially constant as it becomes dry due to the airflow over the component. Over time, the total ventilation flow can return to the original or dry flow. In an example, if the fabric material includes small holes or a tighter weave between textiles, more pressure may be required to clear the water or obstruction in the main vent. Likewise, if the fabric material includes larger holes or a looser, more open weave between textiles, less pressure may be required to clear water or blockages in the primary vents.
[0379] In each of the above embodiments, the diffusion member, such as a fabric material, may include one or more coatings, such as a hydrophobic and / or hydrophilic coating. In one example, a hydrophobic coating may be provided on one side of the fabric (e.g., the patient side) to retain moisture, and a hydrophilic coating may be provided on the other side of the fabric (e.g., the atmosphere side) to prevent moisture from leaving. However, it should be understood that other suitable coating arrangements are also possible.
[0380] 5.3.5 Decoupling structure
[0381] In one form, the patient interface 3000 includes at least one decoupling structure, such as a swivel or a ball and socket.
[0382] 5.3.6 Connection Port
[0383] The connection port 3600 allows connection to the air circuit 4170 .
[0384] 5.3.7 Forehead support
[0385] In one form, the patient interface 3000 includes a forehead support 3700 .
[0386] 5.3.8 Anti-asphyxia valve
[0387] In one form, patient interface 3000 includes an anti-asphyxia valve.
[0388] 5.3.9 Ports
[0389] In one form of the present technology, the patient interface 3000 includes one or more ports that allow access to the volume within the plenum chamber 3200. In one form, this allows the clinician to provide supplemental oxygen. In one form, this allows direct measurement of properties of the gas within the plenum chamber 3200, such as pressure.
[0390] 5.4 Air circuit
[0391] The air circuit 4170 according to one aspect of the present technology is a conduit or tube that is constructed and arranged to allow air flow to flow between two components, such as the RPT device 4000 and the patient interface 3000, when in use.
[0392] In particular, the air circuit 4170 can be fluidly connected to the outlet of the pneumatic block and the patient interface of the RPT device 4000. The air circuit can be referred to as an air delivery tube. In some cases, there can be separate branches for the inspiratory and expiratory circuits. In other cases, a single branch is used.
[0393] In some forms, the air circuit 4170 may include one or more heating elements configured to heat the air in the air circuit, for example to maintain or increase the temperature of the air. The heating element may be in the form of a heating wire loop and may include one or more transducers, such as a temperature sensor. In one form, the heating wire loop may be helically wound around the axis of the air circuit 4170. The heating element may be in communication with a controller, such as a central controller. An embodiment of a control circuit 4170 including a heating wire loop is described in U.S. Patent 8,733,349, which is incorporated herein by reference in its entirety.
[0394] 5.4.1 Oxygen delivery
[0395] In one form of the present technology, supplemental oxygen is delivered to one or more points in the pneumatic pathway, such as upstream of the pneumatic block, the air circuit 4170 and / or the patient interface 3000 .
[0396] 5.5 Terminology
[0397] For purposes of this technical disclosure, one or more of the following definitions may apply in certain forms of the technology. In other forms of the technology, alternative definitions may apply.
[0398] 5.5.1 General terms
[0399] Air: In some forms of the present technology, air may be considered to mean atmospheric air, and in other forms of the present technology, air may be considered to mean some other combination of breathable gases, such as atmospheric air enriched with oxygen.
[0400] Environment: In certain forms of the present technology, the term environment can have the following meanings: (i) external to the treatment system or patient, and (ii) directly surrounding the treatment system or patient.
[0401] For example, the ambient humidity relative to the humidifier may be the humidity of the air directly surrounding the humidifier, such as the humidity within the room that the patient is sleeping in. This ambient humidity may be different from the humidity outside the room that the patient is sleeping in.
[0402] In another example, ambient pressure can be the pressure immediately surrounding or external to the body.
[0403] In some forms, ambient (e.g., acoustic) noise may be considered to be the background noise level in the room the patient is in, in addition to noise generated, for example, by the RPT device or from a mask or patient interface. Ambient noise may be generated by sound sources outside the room.
[0404] Automatic Positive Airway Pressure (APAP) Therapy: CPAP therapy in which the therapy pressure is automatically adjustable between a minimum and a maximum limit, e.g., with each breath, depending on whether there is an indication of a SDB event.
[0405] Continuous Positive Airway Pressure (CPAP) therapy: A breathing pressure therapy in which the therapy pressure can be approximately constant throughout the patient's breathing cycle. In some forms, the pressure at the airway entrance will be slightly higher during exhalation and slightly lower during inspiration. In some forms, the pressure will vary between different breathing cycles of the patient, for example, increasing in response to detecting an indication of partial upper airway obstruction, and decreasing in the absence of an indication of partial upper airway obstruction.
[0406] Flow: Volume (or mass) of air delivered per unit time. Flow may refer to an instantaneous quantity. In some cases, reference to flow will be to a scalar quantity, i.e. a quantity having only magnitude. In other cases, reference to flow will be to a vector quantity, i.e. a quantity having both magnitude and direction. Flow may be given by the symbol Q. 'Flow' is sometimes simply abbreviated to 'flow' or 'airflow'.
[0407] In the example of a patient breathing, the flow may be nominally positive for the inspiratory portion of the patient's breathing cycle, and therefore negative for the expiratory portion of the patient's breathing cycle. The total flow, Qt, is the air flow leaving the RPT device. The ventilation flow, Qv, is the air flow leaving the vent to allow for flushing of exhaled gases. The leakage flow, Ql, is the leakage flow from the patient interface system. The respiratory flow, Qr, is the air flow received into the patient's breathing system.
[0408] Humidifier: The term humidifier is considered to refer to a humidifying device that is constructed and arranged or configured to have a physical structure capable of providing therapeutically beneficial amounts of water (H2O) vapor to an air flow to improve the medical respiratory condition of a patient.
[0409] Leakage: The word leakage is considered to be undesirable air flow. In one example, leakage may occur due to an incomplete seal between the mask and the patient's face. In another example, leakage may occur in the swivel elbow to the surrounding environment.
[0410] Noise, conducted (acoustic): Conducted noise in this document refers to the noise brought to the patient through the pneumatic path (such as the air circuit and patient interface and the air therein). In one form, conducted noise can be quantified by measuring the sound pressure level at the end of the air circuit.
[0411] Noise, radiated (acoustic): Radiated noise in this document refers to the noise that is brought to the patient through the ambient air. In one form, radiated noise can be quantified by measuring the sound power / pressure level of the object in question according to ISO 3744.
[0412] Ventilation noise in this context refers to the noise generated by the flow of air through any vent, such as a vent in a patient interface.
[0413] Patient: A person, whether or not they have a respiratory illness.
[0414] Pressure: Force per unit area. Pressure can be expressed in a range of units, including cmH2O, gf / cm 2 and hectopascal. 1cmH2O is equal to 1g-f / cm 2 , which is approximately 0.98 hectopascals. In this specification, unless otherwise specified, pressure is given in cmH2O.
[0415] The pressure in the patient interface is given the symbol Pm, while the therapy pressure is given the symbol Pt, which represents the target value to be achieved by the mask pressure Pm at the current moment.
[0416] Respiratory Pressure Therapy (RPT): The application of a supply of air to the airway entrance at a therapeutic pressure that is typically positive relative to atmosphere.
[0417] Ventilator: A mechanical device that provides pressure support to a patient to perform some or all of the work of breathing.
[0418] 5.5.1.1 Materials
[0419] Silicone or Silicone Elastomer: Synthetic rubber. In this specification, references to silicone refer to liquid silicone rubber (LSR) or compression molded silicone rubber (CMSR). One form of commercially available LSR is SILASTIC (included in the range of products sold under this trademark), which is manufactured by Dow Corning. Another manufacturer of LSR is Wacker. Unless otherwise specified to the contrary, exemplary forms of LSR have a Shore A (or Type A) indentation hardness in the range of about 35 to about 45 as measured using ASTM D2240.
[0420] Polycarbonate: A thermoplastic polymer of bisphenol A carbonate.
[0421] 5.5.1.2 Mechanical properties
[0422] Elasticity: The ability of a material to absorb energy when it deforms elastically and release that energy when it deflates.
[0423] Resilient: Releases substantially all of its energy when deflated. Includes some silicones and thermoplastic elastomers.
[0424] Hardness: The ability of a material to resist deformation of itself (e.g., as described by Young's modulus, or the indentation hardness scale measured for a standard sample size).
[0425] 'Soft' materials may include silicone or thermoplastic elastomer (TPE), and may deform easily, for example under finger pressure.
[0426] 'Hard' materials may include polycarbonate, polypropylene, steel or aluminium, and may not deform easily under finger pressure, for example.
[0427] Stiffness (or rigidity) of a structure or component: The ability of a structure or component to resist deformation in response to an applied load. The load can be a force or a moment, such as compression, tension, bending or torsion. A structure or component can provide different resistance in different directions.
[0428] Floppy structure or component: A structure or component that will change shape, such as bend, when made to support its own weight for a relatively short period of time, such as 1 second.
[0429] 'Rigid' structure or component: A structure or component that will not substantially change shape when subjected to loads typically encountered in use. One example of this use may be to place and maintain a patient interface in sealing relationship with an entrance to a patient's airway, for example under a load of about 20 to 30 cmH2O pressure.
[0430] As an example, an I-beam may include a different bending stiffness (resistance to bending loads) in a first direction compared to a second, orthogonal direction. In another example, a structure or component is floppy in a first direction and rigid in a second direction.
[0431] 5.5.2 Respiratory cycle
[0432] Apnea: According to some definitions, an apnea is considered to occur when flow drops below a predetermined threshold for a sustained period of time (e.g., 10 seconds). Obstructive apnea is considered to occur when some obstruction of the airway does not allow air to flow despite the patient's efforts. Central apnea is considered to occur when apnea is detected due to a decrease or absence of respiratory effort despite a patent airway. Mixed apnea is considered to occur when a decrease or absence of respiratory effort occurs simultaneously with an obstructed airway.
[0433] Respiratory rate: The rate at which a patient breathes spontaneously, usually measured in breaths per minute.
[0434] Duty cycle: the ratio of inspiratory time Ti to total breathing time Ttot.
[0435] Effort (breathing): The work done by a spontaneous breather in an attempt to breathe.
[0436] Expiratory portion of the respiratory cycle: the period from the start of expiratory flow to the start of inspiratory flow.
[0437] Flow Limitation: Flow limitation is to be considered a state in the patient's breathing where an increase in the patient's effort does not result in a corresponding increase in flow. Where flow limitation occurs during the inspiratory portion of the breathing cycle, it may be described as inspiratory flow limitation. Where flow limitation occurs during the expiratory portion of the breathing cycle, it may be described as expiratory flow limitation.
[0438] Types of flow-limited inspiratory waveforms:
[0439] (i) Flattened: Having a rise followed by a relatively flat portion and then a fall.
[0440] (ii) M-shape: has two local peaks, one at the leading edge and one at the trailing edge, with a relatively flat portion between the two peaks.
[0441] (iii) Chair shape: has a single local peak at the leading edge followed by a relatively flat section.
[0442] (iv) Reverse chair shape: has a relatively flat section followed by a single local peak located at the trailing edge.
[0443] Hypopnea: According to some definitions, hypopnea is considered a decrease in flow, but not a cessation of flow. In one form, hypopnea is considered to occur when flow decreases below a threshold for a sustained period of time. Central hypopnea is considered to occur when hypopnea is detected due to a decrease in respiratory effort. In one form in adults, any of the following may be considered hypopnea:
[0444] (i) The patient's respiration decreases by 30% for at least 10 seconds with an associated 4% desaturation; or
[0445] (ii) The patient's breathing decreases (but less than 50%) for at least 10 seconds, with associated desaturations or arousals of at least 3%.
[0446] Hyperpnea: An increase in flow to a level above normal flow.
[0447] Inspiratory portion of the respiratory cycle: The period from the start of inspiratory flow to the start of expiratory flow is considered the inspiratory portion of the respiratory cycle.
[0448]
[00136] Patency (airway): The degree to which an airway is open or the degree to which an airway is open. An open airway is open. Airway patency can be quantified, for example with a value (1) for open, and a value of zero (0) for closed (obstructed).
[0449] Positive End Expiratory Pressure (PEEP): The pressure above atmospheric pressure that exists in the lungs at the end of exhalation.
[0450] Peak Flow (Q Peak): The maximum value of the flow during the inspiratory portion of the respiratory flow waveform.
[0451] Respiratory flow, patient air flow, respiratory air flow (Qr): These terms may be understood to refer to the RPT device's estimate of respiratory flow, as opposed to "true respiratory flow" or "real respiratory flow", which is the actual respiratory flow experienced by the patient, typically expressed in liters per minute.
[0452] Tidal volume (Vt): The volume of air inhaled or exhaled during normal breathing when no additional effort is exerted. In principle, the inspiratory volume Vi (the volume of air inhaled) is equal to the expiratory volume Ve (the volume of air exhaled), so a single tidal volume Vt can be defined to be equal to either volume. In practice, the tidal volume Vt is estimated as some combination of the inspiratory volume Vi and the expiratory volume Ve, such as an average.
[0453] (Inspiratory) Time (Ti): Duration of the inspiratory portion of the respiratory flow waveform.
[0454] (Expiratory) Time (Te): Duration of the expiratory portion of the respiratory flow waveform.
[0455] (Total) Time (Ttotal): The total duration between the start of the inspiratory portion of a respiratory flow waveform and the start of the inspiratory portion of the subsequent respiratory flow waveform.
[0456] Typical recent ventilation: The ventilation value Vent around which recent values on some predetermined time scale tend to cluster, that is, a measure of the central tendency of recent values of ventilation.
[0457] Upper airway obstruction (UAO): includes partial and total upper airway obstruction. This can be associated with a state of flow limitation, where flow increases only slightly or can even decrease as the pressure difference across the upper airway increases (Starling impedance behavior).
[0458] Ventilation (Vent): A measurement of the flow of gases exchanged by a patient's respiratory system. Measurements of ventilation may include one or both of inspiratory and expiratory flow (per unit time). When expressed as a volume per minute, this quantity is often referred to as "minute ventilation". Minute ventilation is sometimes given simply as volume, and is understood to be the volume per minute.
[0459] 5.5.3 Ventilation
[0460] Adaptive servo ventilator (ASV): A servo ventilator with a variable rather than fixed target ventilation. The variable target ventilation may be derived from some characteristics of the patient, such as the patient's breathing characteristics.
[0461] Backup Rate: A parameter of a ventilator that determines the minimum respiratory rate (usually measured in breaths per minute) that the ventilator will deliver to a patient if not triggered by a spontaneous respiratory effort.
[0462] Cyclic: The termination of the inspiratory phase of a ventilator. When a ventilator is delivering a breath to a spontaneously breathing patient, at the end of the inspiratory portion of the respiratory cycle, the ventilator is considered to cycle to stop delivering a breath.
[0463] Expiratory Positive Airway Pressure (EPAP): The base pressure to which the intra-breath varying pressures are added to produce the desired mask pressure that the ventilator will attempt to achieve at a given time.
[0464] End-expiratory pressure (EEP): The desired mask pressure that the ventilator attempts to achieve at the end of the expiratory portion. If the pressure waveform template P(F) is zero at the end of exhalation, that is, P(F) = 0 when F = 1, then EEP is equal to EPAP.
[0465] Inspiratory Positive Airway Pressure (IPAP): The maximum desired mask pressure that the ventilator attempts to achieve during the inspiratory portion of a breath.
[0466] Pressure Support: A number that indicates the increase in pressure during ventilator inspiration over the pressure during ventilator expiration, and usually means the difference in pressure between the maximum during inspiration and the base pressure (e.g., PS = IPAP - EPAP). In some cases, pressure support means the difference that the ventilator aims to achieve, rather than the difference that is actually achieved.
[0467] Servomotor: A ventilator that measures patient ventilation, has a target ventilation and adjusts the level of pressure support to bring the patient's ventilation to the target ventilation.
[0468] Spontaneous / Timed (S / T): A mode of a ventilator or other device that attempts to detect the onset of a breath in a spontaneously breathing patient. However, if the device cannot detect a breath within a predetermined period of time, the device will automatically initiate the delivery of a breath.
[0469] Swing: A term equivalent to pressure support.
[0470] Triggered: When the ventilator delivers breathed air to a spontaneously breathing patient, it is considered to be triggered at the beginning of the breath portion of the breathing cycle through the patient's effort.
[0471] 5.5.4 Anatomy
[0472] 5.5.4.1 Facial anatomy
[0473] Ala: The outer wall or "wing" of each nostril (plural: alar).
[0474] Nose angle:
[0475] Alar tip: The outermost point on the wing of the nose.
[0476] Alar bend (or alar apex) point: The most posterior point in the base line of the curvature of each ala, found in the crease formed by the union of the ala and cheek.
[0477] Auricle: The entire external visible part of the ear.
[0478] (Nose) Framework: The nasal framework includes the nasal bones, the frontal process of the maxilla, and the nasal part of the frontal bone.
[0479] (Nose) Soft skeleton: The nasal soft skeleton includes the septal, lateral, major and minor cartilages.
[0480] Columella: The strip of skin that separates the nostrils and extends from the nasal prominence to the upper lip.
[0481] Columellar angle: the angle between a line drawn through the midpoint of the nostril and a line drawn perpendicular to the Frankfurt plane (where both lines intersect at the lower point of the nasal septum).
[0482] Frankfurt plane: A line extending from the lowest point of the orbital rim to the left cochlea. The cochlea is the deepest point in the notch above the tragus of the auricle.
[0483] Glabella: The most prominent point on the soft tissue of the forehead in the mid-sagittal plane.
[0484] External nasal cartilage: A cartilaginous plate that is essentially triangular in shape. Its upper edge is attached to the nasal bone and the frontal process of the maxilla, and its lower edge is connected to the greater alar cartilage.
[0485] Lip, lower (midpoint of lower lip):
[0486] Lip, upper (midpoint of upper lip):
[0487] Greater alar cartilage: A cartilaginous plate located beneath the external nasal cartilage. It curves around the front of the nostril. Its rear end is connected to the frontal process of the maxilla by a tough fibrous membrane consisting of three or four small cartilages of the alar nasal cavity.
[0488] Nare: The roughly oval-shaped hole that forms the entrance to the nasal cavity. The singular form of nare is naris (nare). The nostrils are separated by the nasal septum.
[0489] Nasolabial folds or nasolabial wrinkles: Folds or grooves of skin that extend from each side of the nose to the corners of the mouth, separating the cheeks from the upper lip.
[0490] Nasolabial angle: the angle between the columella and the upper lip (which intersect at the lower point of the nasal septum).
[0491] Auricular base: The lowest point where the auricle attaches to the facial skin.
[0492] Auricular base: The highest point where the auricle attaches to the facial skin.
[0493] Nasal prominence: The most prominent point or tip of the nose that can be identified in a side view of the rest of the head.
[0494] Philtrum: The midline groove that extends from the lower border of the nasal septum to the top of the lip in the upper lip area.
[0495] Mental point: The midpoint of the frontmost part of the chin located on the soft tissue.
[0496] Ridge (nose): The nasal ridge is the midline protrusion of the nose extending from the nasal bridge point to the nasal protuberance point.
[0497] Sagittal plane: A vertical plane running from front (anterior) to back (posterior). The midsagittal plane is the one that divides the body into right and left halves.
[0498] Nasal point: The most concave point on the soft tissue covering the frontonasal suture area.
[0499] Septal Cartilage (Nose): The septal cartilage forms part of the septum and divides the front of the nasal cavity.
[0500] Posterior superior lateral flap: The point at the inferior edge of the alar base where the alar base joins the skin of the upper (superior) lip.
[0501] Subseptal point: The point located on the soft tissue at the intersection of the columella and upper lip in the midsagittal plane.
[0502] Mandibular alveolar seat point: The point of maximum concavity on the midline of the lower lip between the midpoint of the lower lip and the premental point of the soft tissue.
[0503] 5.5.4.2 Skull anatomy
[0504] Frontal Bone: The frontal bone includes a large vertical portion (the squama) which corresponds to the area called the forehead.
[0505] Mandible: The mandible forms the lower jaw. The mental protuberance is the bony protuberance of the lower jaw that forms the chin.
[0506] Maxilla: The maxilla forms the upper jaw and lies above the mandible and below the eye sockets. The frontal process of the maxilla projects upward from the sides of the nose and forms part of the lateral border.
[0507] Nasal bones: The nasal bones are two small, oblong bones that vary in size and shape in different individuals; they lie side by side in the middle and upper parts of the face and form the "bridge" of the nose at their junction.
[0508] Nasion: The intersection of the frontal bone and the two nasal bones, the concave area directly between the eyes and on the upper part of the bridge of the nose.
[0509] Occipital Bone: The occipital bone is located at the back and lower part of the skull. It contains the oval hole (foramen magnum) through which the cranial cavity communicates with the vertebral canal. The curved plate behind the foramen magnum is the squama occipitalis.
[0510] Orbit: The bony cavity in the skull that holds the eyeball.
[0511] Parietal bones: The parietal bones are the bones that when joined together form the roof and sides of the skull.
[0512] Temporal Bones: The temporal bones are located at the base and sides of the skull and support the part of the face called the temples.
[0513] Zygomatic bones: The face includes two zygomatic bones, which are located on the upper and side parts of the face and form the protrusions of the cheeks.
[0514] 5.5.4.3 Anatomy of the respiratory system
[0515] Diaphragm: A sheet of muscle that extends across the base of the rib cage. The diaphragm separates the thoracic cavity, which contains the heart, lungs, and ribs, from the abdominal cavity. As the diaphragm contracts, the volume of the thoracic cavity increases and air is drawn into the lungs.
[0516] Larynx: The larynx or voice box houses the vocal cords and connects the lower part of the pharynx (hypopharynx) to the trachea.
[0517] Lung: The respiratory organ of humans. The conducting zone of the lungs contains the trachea, bronchi, bronchioles, and terminal bronchioles. The respiratory zone contains the respiratory bronchioles, alveolar ducts, and alveoli.
[0518] Nasal Cavity: The nasal cavity (or nasal fossa) is a large air-filled space above and behind the nose in the middle of the face. The nasal cavity is divided into two parts by a vertical wing called the nasal septum. On the sides of the nasal cavity are three horizontal branches called the nasal conchae (singular "concha") or turbinates. The front of the nasal cavity is the nose, while the back joins into the nasopharynx via the internal nostrils.
[0519] Pharynx: The part of the throat located just below (under) the nasal cavity and above the esophagus and larynx. The pharynx is conventionally divided into three sections: the nasopharynx (epipharynx) (nasal portion of the pharynx), the oropharynx (mesopharynx) (oral portion of the pharynx), and the hypopharynx (hypopharynx).
[0520] 5.5.5 Patient interface
[0521] Anti-Asphyxia Valve (AAV): A component or subcomponent of a mask system that reduces the risk of excessive CO2 rebreathing by the patient by opening to atmosphere in a fail-safe manner.
[0522] Elbow: An elbow is an example of a structure that directs the axis of an air flow to change direction through a certain angle. In one form, the angle can be about 90 degrees. In another form, the angle can be greater or less than 90 degrees. The elbow can have a cross-section that is approximately circular. In another form, the elbow can have an elliptical or rectangular cross-section. In some forms, the elbow can be rotated relative to a mating component, for example, through about 360 degrees. In some forms, the elbow can be removable from a mating component, such as by a snap connection. In some forms, the elbow can be assembled to the mating component during the manufacturing process with a disposable snap, but cannot be removed by the patient.
[0523] Frame: A frame will be considered to mean the mask structure that carries the tensile load between two or more connection points to the headgear. A mask frame may be a non-airtight load-bearing structure in a mask. However, some forms of mask frames may also be airtight.
[0524] Headgear: A headgear will be considered to mean a form of positioning and stabilizing structure designed for use on the head. For example, a headgear may include a collection of one or more support bars, straps, and reinforcement bars configured to position and maintain a patient interface in position on a patient's face for delivery of respiratory therapy. Some straps are formed of soft, flexible, resilient materials, such as laminate composites of foam and textiles.
[0525] Film: A film shall be taken to mean a typically thin element which preferably has substantially no resistance to bending, but has resistance to stretching.
[0526] Plenum: A mask plenum will be taken to mean a portion of the patient interface having walls at least partially enclosing a volume of space which, in use, has air pressurized therein to above atmospheric pressure. The housing may form part of the wall of the mask plenum.
[0527] Seal: can be a noun indicating structure ("seal") or a verb indicating action ("to seal"). Two elements can be constructed and / or arranged to seal between them or achieve a "seal" between them without the need for a separate "sealing" element itself.
[0528] Shell: Shell will be taken to mean a curved and relatively thin structure having a bendable, stretchable and compressible stiffness. For example, a curved structural wall of a mask may be a shell. In some forms, the shell may be multi-faceted. In some forms, the shell may be airtight. In some forms, the shell may not be airtight.
[0529] Reinforcement: A reinforcement will be taken to mean a structural component designed to increase the bending resistance of another component in at least one direction.
[0530] Braces: Braces will be considered to be structural components designed to increase the compression resistance of another component in at least one direction.
[0531] Swivel (n): A subassembly of a component configured to rotate about a common axis, preferably independently, preferably under low torque. In one form, the swivel may be configured to rotate through an angle of at least 360 degrees. In another form, the swivel may be configured to rotate through an angle of less than 360 degrees. When used in the context of an air delivery conduit, the subassembly of the component preferably comprises a pair of matching cylindrical conduits. There may be little or no air flow leakage from the swivel when in use.
[0532] Tie (noun): A structure designed to resist tension.
[0533] Vent: (noun): A structure that allows air flow from the interior of a mask or duct to ambient air, e.g., to allow effective flushing of exhaled gases. For example, clinically effective flushing may involve a flow rate of about 10 liters per minute to about 100 liters per minute, depending on the mask design and the treatment pressure.
[0534] 5.5.6 Shape of the structure
[0535] Products according to the present technology may include one or more three-dimensional mechanical structures, such as a mask cushion or a thruster. The three-dimensional structures may be combined by two-dimensional surfaces. These surfaces may be distinguished using markings to describe the relative surface orientation, position, function, or some other feature. For example, a structure may include one or more of a front surface, a rear surface, an inner surface, and an outer surface. In another example, a seal-forming structure may include a face-contacting (e.g., outer) surface and a separate non-face-contacting (e.g., underside or inner) surface. In another example, a structure may include a first surface and a second surface.
[0536] To help describe the shape of three-dimensional structures and surfaces, we first consider a cross section through a point p on the surface of the structure. FIG. 3B to FIG. 3F , which show examples of cross sections at a point p on the surface and the resulting plane curve. FIG. 3B to FIG. 3F The outward normal vector at point p is also shown. The outward normal vector at point p points away from the surface. In some examples, the surface is described from the point of view of an imaginary person standing upright on the surface.
[0537] 5.5.6.1 Curvature in one dimension
[0538] The curvature of a plane curve at p can be described as having a sign (eg, positive, negative) and a magnitude (eg, the inverse of the radius of a circle that touches the curve only at p).
[0539] Positive curvature: If the curve at p turns toward the outward normal, then the curvature at that point will be positive (if the imaginary person were to leave that point p, they would have to walk uphill). Figure 3B (and Figure 3C Compared with the relatively large positive curvature) and Figure 3C (and Figure 3B Such curves are often called concave.
[0540] Zero curvature: If the curve at point p is a straight line, then the curvature will be zero (if the imaginary person leaves point p, they can walk horizontally without going up or down). Figure 3D .
[0541] Negative curvature: If the curve at point p turns away from the outward normal, then the curvature in that direction at that point will be negative (if the imaginary person were to leave that point p, they would have to go downhill). Figure 3E (and Figure 3F Compared to the relatively small negative curvature) and Figure 3F (and Figure 3E Such curves are often called convex.
[0542] 5.5.6.2 Curvature of a Two-Dimensional Surface
[0543] A description of a shape at a given point on a two-dimensional surface according to the present technology may include multiple normal cross sections. Multiple cross sections may cut the surface in a plane that includes the outward normal ("normal plane"), and each cross section may be taken in a different direction. Each cross section produces a planar curve with a corresponding curvature. The different curvatures at the point may have the same sign or different signs. Each curvature at the point has a magnitude, such as a relatively small magnitude. FIG. 3B to FIG. 3F The plane curve in can be an example of such multiple cross sections at specific points.
[0544] Principal curvatures and principal directions: The directions of the normal planes where the curvature of the curve takes its maximum and minimum values are called principal directions. FIG. 3B to FIG. 3F In the example of Figure 3B and the minimum value appears at Figure 3F Therefore Figure 3B and Figure 3F is the cross section in the principal direction. The principal curvature at p is the curvature in the principal direction.
[0545] Region of a surface: A connected set of points on a surface. The points in a region can have similar characteristics, such as curvature or sign.
[0546] Saddle region: A region where at each point the principal curvatures have opposite signs, ie one sign is positive and the other sign is negative (depending on the direction the imagined individual is turning, they can be walking up or down).
[0547] Dome region: The region where at every point the principal curvatures have the same sign, e.g. two positive ("concave dome") or two negative ("convex dome").
[0548] Cylindrical region: A region where one of the principal curvatures is zero (or is zero, for example, within manufacturing tolerances) and the other principal curvature is non-zero.
[0549] Planar region: A surface region where both principal curvatures are zero (or are zero within manufacturing tolerances, for example).
[0550] Edge of a surface: The boundary or limit of a surface or area.
[0551] Path: In some forms of the present technology, a 'path' will be taken to mean a path in a mathematical-topological sense, e.g. a continuous spatial curve from f(0) to f(1) on a surface. In some forms of the present technology, a 'path' may be described as a route or course comprising, e.g., a set of points on a surface. (An imagined individual's path is one in which they walk on a surface and is similar to a garden path).
[0552] Path length: In some forms of the present technology, 'path length' will mean the distance along the surface from f(0) to f(1), i.e. the distance along a path on the surface. There may be more than one path between two points on the surface and such paths may have different path lengths. (The path length of an imaginary individual would be the distance they walked along the path on the surface).
[0553] Straight-line distance: Straight-line distance is the distance between two points on a surface, but regardless of the surface. In a planar region, there can be a path on the surface that has the same path length as the straight-line distance between two points on the surface. In a non-planar surface, there can be no path that has the same path length as the straight-line distance between two points. (For an imaginary individual, straight-line distance would correspond to the distance as a 'straight line'.)
[0554] 5.5.6.3 Space curve
[0555] Space curves: Unlike plane curves, space curves do not have to lie in any particular plane. Space curves can be closed, i.e. have no endpoints. Space curves can be thought of as one-dimensional slices of three-dimensional space. An imaginary individual walking on a DNA helix walks along a space curve. A typical human left ear consists of a helix, i.e., the left helix, see Figure 3Q The typical human right ear includes a helix, the right helix, cf. Figure 3R . Figure 3S A right-handed spiral is shown. The edge of a structure, such as the edge of a membrane or propeller, can follow a space curve. In general, a space curve can be described by the curvature and twist at each point on the space curve. Twist is a measure of how the curve departs from the surface. Twist has a sign and a magnitude. The twist at a point on a space curve can be characterized with reference to the tangent, normal, and binormal vectors at that point.
[0556] Tangent unit vector (or unit tangent vector): For each point on a curve, the vector at that point indicates the direction from that point as well as the amount. The tangent unit vector is a unit vector pointed in the same direction as the curve at that point. If an imaginary individual were flying along the curve and stopped at a particular point, the direction of the tangent vector is the direction it would be traveling.
[0557] Unit Normal Vector: As the imaginary individual moves along the curve, this tangent vector itself changes. The unit vector pointing in the same direction that the tangent vector is changing is called the unit principal normal vector. It is perpendicular to the tangent vector.
[0558] Binormal unit vector: The binormal unit vector is perpendicular to the tangent vector and the principal normal vector. Its direction can be determined by the right-hand rule (see, e.g. Figure 3P ) or alternatively by the left-hand rule ( Fig.3O ) to determine.
[0559] Osculating plane: The plane containing the unit tangent vector and the unit principal normal vector. Fig.3O and Figure 3P .
[0560] Torsion of a space curve: The torsion at a point on a space curve is the amount of rate of change of the binormal vector at that point. It measures how much the curve deviates from the osculating plane. A space curve that lies on a plane has zero torsion. A space curve that deviates from the osculating plane by a relatively small amount will have a relatively small amount of torsion (e.g., a slightly tilted spiral path). A space curve that deviates from the osculating plane by a relatively large amount will have a relatively large amount of torsion (e.g., a sharply tilted spiral path). Figure 3S , although T2>T1, in Figure 3S The number of twists near the top helical coil is greater than Figure 3S The number of twists in the bottom helical coil.
[0561] refer to Figure 3P According to the right-hand rule, a space curve that turns in the direction of the right-hand binormal can be considered to have right-hand positive twist (for example, Figure 3S A space curve that deviates away from the right-handed binormal direction can be considered to have right-handed negative twist (e.g., a left-handed helix).
[0562] Similarly and referring to the left-hand rule (see Fig.3O ), a space curve that turns in the direction of the left-handed binormal can be considered to have left-handed positive twist (e.g., a left-handed helix). Thus, left-handed positive twist is equivalent to right-handed negative twist. Figure 3T .
[0563] 5.5.6.4 Holes
[0564] A surface may have one-dimensional pores, for example pores defined by a plane curve or by a space curve. A thin structure (e.g., a membrane) having pores may be described as having one-dimensional pores. For example, see Fig. 3I A one-dimensional hole in the surface of the structure shown in , which is defined by a plane curve.
[0565] The structure may have a two-dimensional aperture, such as an aperture defined by a surface. For example, an inflatable tire has a two-dimensional aperture defined by the inner surface of the tire. In another example, a bladder having a cavity for air or gel has a two-dimensional aperture. See, e.g. Figure 3L Cushions and Figure 3M and Figure 3N An exemplary cross section through a catheter is shown, wherein the inner surface defining the two-dimensional hole is shown. In another example, the catheter can include a one-dimensional hole (e.g., at its inlet or at its outlet) and a two-dimensional hole defined by the inner surface of the catheter. See also Figure 3K The two-dimensional pores of the structure shown are defined by the surfaces shown.
[0566] 5.6 Other notes
[0567] Unless the context clearly indicates and provides a numerical range, it should be understood that each intervening value between the upper and lower limits of the range, to one-tenth of the unit of the lower limit, and any other value or intermediate value in the range are broadly included in the present technology. The upper and lower limits of these intermediate ranges may be independently included in the intermediate ranges and are also included in the present technology, but are subject to any explicitly excluded limits in the range. In the case where the range includes one or two of the limits, the present technology also includes ranges excluding any one or two of those included limits.
[0568] Furthermore, where a value or values are described herein for implementation as part of the present technology, it should be understood that such values may be approximate unless otherwise indicated and that such values may be used to any appropriate number of significant digits to the extent that practical technical implementations may permit or require it.
[0569] Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which the technology belongs. Although any methods and materials similar or equivalent to those described herein can also be used in the practice or testing of the technology, a limited number of representative methods and materials are described herein.
[0570] When a specific material is identified for use in constructing a component, obvious alternative materials having similar properties are substituted therefor. In addition, unless otherwise specified, any and all components described herein are understood to be capable of being manufactured and thus may be manufactured together or separately.
[0571] It must be noted that as used herein and in the appended claims, the singular forms "a," "an," and "the" include plural equivalents unless the context clearly dictates otherwise.
[0572] All publications mentioned herein are incorporated herein in their entirety by reference, to disclose and describe methods and / or materials as the subject of those publications. Providing the publications discussed herein is only for the disclosures before the filing date of the present application. Anything herein should not be construed as admitting that the present technology is not entitled to the priority of these publications due to previous inventions. In addition, the publication date provided may be different from the actual publication date, which may need to be confirmed separately.
[0573] The terms "comprises" and "comprising" should be understood to refer to each element, component or step in a non-exclusive manner, indicating that the marked elements, components or steps may be present or utilized, or in combination with other elements, components or steps that are not marked.
[0574] The subject headings used in the detailed description are for the convenience of the reader and should not be used to limit the subject matter that can be found in the entire disclosure or claims. The subject headings should not be used to interpret the scope of the claims or the limitations of the claims.
[0575] Although the technology herein has been described with reference to specific examples, it should be understood that these examples only illustrate the principles and applications of the technology. In some cases, terms and symbols may mean specific details that are not required for practicing the technology. For example, although the terms "first" and "second" may be used, unless otherwise specified, they are not intended to indicate any order, but can be used to distinguish different elements. In addition, although the process steps in the method can be described or shown in order, such order is not necessary. Those skilled in the art will recognize that such an order can be modified and / or various aspects thereof can be performed simultaneously or even synchronously.
[0576] It is therefore to be understood that numerous modifications may be made to the illustrative examples and that other arrangements may be devised without departing from the spirit and scope of the present technology.
[0577] 5.7 Reference Symbols List
[0578]
[0579]
[0580]
Claims
1. A CPAP system for providing positive pressure gas for respiratory therapy to a patient, the CPAP system include: an RPT device configured to provide a flow of gas at a therapeutic pressure; a patient interface forming an inflatable chamber pressurizable to the therapy pressure, the patient interface including a seal-forming structure configured to form a seal with an area of the patient's face surrounding an entrance to the patient's airway; an air delivery conduit configured to deliver the gas flow at the therapeutic pressure from the RPT device to the patient interface; as well as A ventilation assembly configured to provide a ventilation flow of gas to expel gas exhaled by the patient from a pressurized volume to an ambient environment, the ventilation assembly comprising: a base comprising at least one first aperture extending through the base to allow gas to be exhausted from the pressurized volume to the surrounding environment along a primary ventilation flow path, and at least one second aperture to allow gas to be exhausted from the pressurized volume to the surrounding environment along a secondary ventilation flow path; a diffuser member disposed on the base, the diffuser member configured and arranged such that the at least one first aperture is covered by the diffuser member such that the ventilation flow passes through the diffuser member along the primary ventilation flow path, and the at least one second aperture is not covered by the diffuser member such that the ventilation flow bypasses the diffuser member along the secondary ventilation flow path; and a membrane disposed to the base, wherein the membrane is configured and arranged to distribute the ventilation flow of gas along the primary ventilation flow path and the auxiliary ventilation flow path throughout a respiratory therapy session, wherein due to the pressure within the pressurized volume, the membrane is movable to an activated position to cover and close the at least one second orifice such that the ventilation flow of gas is restricted to the primary ventilation flow path, and When the diffusion member is blocked along the primary vent flow path, the membrane is movable to uncover and open the at least one second aperture such that the gas vent flow is restricted to the secondary vent flow path.
2. The CPAP system according to claim 1, in, The ventilation assembly is disposed to the patient interface.
3. The CPAP system according to claim 1, in, The vent assembly is disposed to the air delivery conduit.
4. The CPAP system according to any one of claims 1 to 3, in, The diffuser member comprises a fabric material.
5. The CPAP system according to any one of claims 1 to 3, further comprising a cover holding the diffusion member to the base.
6. The CPAP system according to any one of claims 1 to 3, in, The diffuser member includes at least one aperture arranged to align with the at least one second aperture of the base.
7. The CPAP system according to any one of claims 1 to 3, in, The membrane includes an orifice arranged to be aligned with the at least one first orifice of the base in the activated position, and the size of the orifice of the membrane is set to regulate the gas ventilation flow so that the gas ventilation flow through the orifice of the membrane flows at a constant flow rate within a therapeutic pressure range.
8. The CPAP system according to any one of claims 1 to 3, in, When the diffuser member is blocked due to water or moisture, the auxiliary ventilation flow path bypasses the diffuser member to allow the gas ventilation flow.
9. The CPAP system according to any one of claims 1 to 3, in, When the ventilation flow along the primary ventilation flow path is gradually reduced due to the obstruction of the diffusion member, the membrane may be gradually moved to not cover the at least one second aperture and the auxiliary ventilation flow path.
10. The CPAP system of any one of claims 1 to 3, further comprising an activator configured and arranged to deflect the membrane to distribute the ventilation flow of gas along the primary ventilation flow path and the auxiliary ventilation flow path.
11. The CPAP system according to claim 10, in, The activator includes an expanded polymer material.
12. The CPAP system according to claim 10, in, The activator is configured to expand when exposed to water or moisture to deflect the membrane and uncover the primary ventilation flow path.
13. The CPAP system according to claim 12, in, The activator includes a sensor configured to detect water and actuate the activator when water is detected.
14. A CPAP system according to any one of claims 1 to 3, wherein the membrane comprises a flap portion pivotally movable relative to the base.
15. The CPAP system of claim 14, wherein the flap portion includes an aperture configured and arranged to align with the at least one first aperture of the base.
16. A vent assembly configured to provide a vent flow of gas to exhaust gas from a pressurized volume to a surrounding environment, the vent assembly include: at least one first orifice to allow gas to vent from the pressurized volume to the surrounding environment along a primary ventilation flow path; at least one second orifice to allow gas to vent from the pressurized volume to the surrounding environment along the auxiliary ventilation flow path; a diffuser member configured and arranged such that the at least one first aperture is covered by the diffuser member such that ventilation flow passes through the diffuser member along the primary ventilation flow path, and the at least one second aperture is not covered by the diffuser member such that ventilation flow bypasses the diffuser member along the secondary ventilation flow path; as well as a membrane configured and arranged to distribute the gas ventilation flow along the primary ventilation flow path and the auxiliary ventilation flow path, wherein due to the pressure within the pressurized volume, the membrane is movable to an activated position to cover and close the at least one second orifice such that the ventilation flow of gas is restricted to the primary ventilation flow path, and When the diffusion member is blocked along the primary vent flow path, the membrane is movable to uncover and open the at least one second aperture such that the gas vent flow is restricted to the secondary vent flow path.
17. The vent assembly according to claim 16, in, The diffusion member includes at least one aperture arranged to align with the at least one second aperture.
18. A vent assembly according to claim 16 or 17, wherein the membrane comprises a pivotally movable flap portion.
19. A vent assembly according to claim 16 or 18, wherein the pivotally moveable flap portion comprises an aperture configured and arranged to align with the at least one first aperture.
20. A patient interface for delivering a supply of pressurized gas to an airway entrance of a patient, the patient interface comprising a ventilation assembly according to any one of claims 16 to 19.
21. An air delivery conduit for passing a flow of gas between two components, the air delivery conduit comprising a ventilator assembly according to any one of claims 16 to 19.
22. A patient interface configured to deliver a positive pressure gas supply to an airway entrance of a patient for respiratory therapy, the patient interface include: a plenum chamber that can be pressurized to a therapeutic pressure above ambient air pressure; a seal-forming structure configured to form a seal with an area of the patient's face surrounding an entrance to the patient's airway; as well as A ventilation assembly configured to provide a ventilation flow of gas to discharge gas exhaled by the patient from the plenum chamber to an ambient environment, the ventilation assembly comprising: a base comprising: at least one first aperture extending through the base to allow gas to be exhausted from the pressurized volume to the surrounding environment along a primary ventilation flow path; and at least one second aperture allowing gas to be exhausted from the pressurized volume to the surrounding environment along a secondary ventilation flow path; a membrane disposed on the base, wherein the membrane is configured and arranged to distribute the ventilation flow of gas along the primary ventilation flow path and the auxiliary ventilation flow path throughout a respiratory therapy session; and an activator configured and arranged to deflect the membrane to distribute the ventilation flow of gas along the primary ventilation flow path and the auxiliary ventilation flow path, Wherein the activator comprises a sensor configured to actuate the activator.
23. A patient interface according to claim 22, wherein the sensor includes a circuit track configured and arranged to detect water and to actuate the activator when water is detected.
24. An activator for a patient interface, include: a sensor configured to actuate the activator to deflect the membrane to distribute a ventilation flow of gas, The sensor is configured to activate an electronic switch, which actuates the activator.
25. The activator of claim 24, further comprising a moving member configured to engage with the membrane and deflect the membrane.
26. A patient interface configured to deliver a positive pressure gas supply to an airway entrance of a patient for respiratory therapy, said patient interface include: a plenum chamber that can be pressurized to a therapeutic pressure above ambient air pressure; a seal-forming structure configured to form a seal with an area of the patient's face surrounding an entrance to the patient's airway; as well as A ventilation assembly configured to provide a ventilation flow of gas to discharge gas exhaled by the patient from the plenum chamber to an ambient environment, the ventilation assembly comprising: a base comprising: at least one first aperture extending through the base to allow gas to be exhausted from the plenum along a primary ventilation flow path to an ambient environment; and at least one second aperture to allow gas to be exhausted from the plenum along a secondary ventilation flow path to an ambient environment; a diffuser member provided to the base, the diffuser member configured and arranged such that the at least one first aperture is covered by the diffuser member along the primary ventilation flow path and the at least one second aperture is not covered by the diffuser member along the secondary ventilation flow path, wherein the diffuser member comprises a fabric material; and a vent member provided to the at least one second aperture of the base, the vent member comprising a plurality of vent apertures, Wherein the ventilation component comprises an expanded polymer material constructed and arranged to regulate the ventilation flow of gas along the auxiliary ventilation flow path throughout respiratory therapy.
Citation Information
Patent Citations
Methods and devices for providing inspiratory and expiratory flow relief during ventilation therapy
CN101873875A
Exchanger assembly for respiratory treatment
CN104114218A
Vent and / or diverter assembly for use in breathing apparatus
US20040255948A1
Multidose substance delivery module
WO2014184044A1
